Product Range INDIAN

IMMUNOLOGICALS
LIMITED

Vaccines For Canine Animal Health Human Health

Live Stock Vaccines Formulations Vaccines
1. Raksha 1. Raksharab 1. Ivectin 22. Gyroflox Inj. 1. Abhayrab (B.P.)
2. Raksha Monovalent 2. Megavac-6 2. Vetalben 2.5% 23. Gyroflox tab. 2. Abhay RIG
3. Raksha Bivalent 3. Megavac-P (Inact) 3. Vetalben 10% 24. Gyroflox 10% 3. Abhay-Vac 3
4. Raksha Trivalent 4. Megavac-CC 4. Vetalben T 25. Inimox 4. Abhay-M
5. Raksha Ovac 5. Vetalben 300 26. G-cin Inj. 5. Abhay-M (I.P.)
6. Raksha Ovac Monovalent 6. Vetalben 600 27. Sulfamin 6. Elovac-B
7. Vetalben Forte 28. Vetylosin 5% Inj. 7. Abhay-TOX
7. Raksha Ovac Bivalent
8. Vetfen 29. Lithiomony
8. Raksha Ovac Trivalent 8. Abhay-DAG
9. Vetfen - B 30. Inigesic
9. Raksha Biovac 9. Abhay-TAG
10. Prazital 31. Nimovet
10. Raksharab
11. Prazital Plus 32. Pesurea Bolus
11. Raksha - SP
12. Levaxinide 33. Calgonate
12. Raksha HS 13. Rafonide 34. Miphocal
13. Raksha BQ 14. Trichloben 35. Bovoplex - CC
14. Raksha HS+BQ 15. Prozal 36. Mastect
15. Rakshavac-T 16. Trepanol 37. Xylaxin
16. Raksha Anthrax 17. Tikkil Powder 38. Trophovet
17. Bruvax 18. Tikkil Solution
18. Bruvax REV1 19. Oxytetracycline 5% Inj.
19. Raksha ET 20. Tetroxin - DS
20. Raksha PPR 21. Tetroxin - LA

Raksha
(FOOT AND MOUTH DISEASE VACCINE BP (Vet))
Raksha FMD(Foot and Mouth Disease) vaccine is recommended for prophylactic
vaccination against Foot and Mouth Disease in cattle, buffaloes, sheep and goats.
Raksha FMD vaccine is manufactured by Indian Immunologicals with the process
know-how obtained from the Wellcome Foundation Ltd. U.K., the pioneers and world
leaders in FMD research, control and vaccine production.
COMPOSITION
Raksha FMD vaccine contains tissue culture inactivated FMD virus strains O, A, C
and Asia-1 adsorbed on Aluminium hydroxide and Saponin added as an adjuvant.
ADMINISTRATION
The vaccine vial should be kept cold until used and each vial should be well shaken
before contents are withdrawn. Syringes and needles must be sterilized before use.
The vaccine should be injected subcutaneously through an area of clean, dry skin
with precautions taken against contamination. The chest wall behind the shoulder or
the dewlap are the recommended sites for inoculation.
DOSAGE
Cattle, Buffaloes and Calves : 3 ml & Sheep and Goats : 1 ml
VACCINATION REGIMEN
Primary vaccination : 4 months of age.
Booster : 2 to 4 weeks after primary vaccination.
Revaccination : Every 6 months thereafter.
Primovaccinates irrespective of age should receive two doses initially. This should be
followed
by every 6 months thereafter.
SIDE EFFECTS
Generally no significant side effects are noticed after vaccination. However, in a few
cases a small swelling may develop at the site of inoculation, which usually subsides
within a few days. The body temperature generally remains normal.
BACK
TO
PRODUCT
RANGE
STORAGE AND TRANSPORT
The vaccine should be stored and transported between 2°C and 8°C. Antigenicity of
the vaccine deteriorates if the temperature is allowed to rise above this range, the
rate of deterioration depending on both temperature and time. At no stage should the
vaccine be frozen.
PRESENTATION
Raksha FMD vaccine is available in polypropylene bottles of 10 doses (30 ml) & 100
doses (300 ml).
CAUTION
Raksha FMD vaccine is thoroughly tested before issue. As subsequent handling and
administration are not controlled by the manufacturers or distributors/stockists, no
responsibility following their use can be accepted. Raksha FMD vaccine is issued
subject to this condition. Under field conditions it is extremely difficult to avoid the
accidental introduction of bacteria when withdrawing doses of Raksha FMD vaccine
from the containers. Part-used bottles of vaccine should therefore be discarded at the
end of the day’s operations.
Aqueous or Oil adjuvant vaccines, monovalent, bivalent, trivalent, quadrivalent
or any other valency incorporating the most relevant strains of epidemiological
significance can be manufactured as per customer’s choice.
 BACK
TO

Raksha Monovalent PRODUCT

RANGE

(FOOT AND MOUTH DISEASE VACCINE BP (Vet))

Raksha Monovalent FMD (Foot and Mouth Disease) vaccine is recommended for
prophylactic vaccination against Foot and Mouth Disease in cattle, buffaloes, sheep
and goats.

Raksha FMD vaccine is manufactured by Indian Immunologicals with the process

know-how obtained from the Wellcome Foundation Ltd. U.K., the pioneers and world
leaders in FMD research, control and vaccine production.

COMPOSITION within a few days. The body temperature generally remains normal.
Raksha Monovalent FMD vaccine contains tissue culture inactivated FMD virus strain
O1 Manisa (monovalent) adsorbed on Aluminium hydroxide and Saponin added as STORAGE AND TRANSPORT
an adjuvant. The vaccine should be stored and transported between 2°C and 8°C. Antigenicity of
the vaccine deteriorates if the temperature is allowed to rise above this range, the
ADMINISTRATION rate of deterioration depending on both temperature and time. At no stage should the
The vaccine vial should be kept cold until used and each vial should be well shaken vaccine be frozen.
before contents are withdrawn. Syringes and needles must be sterilized before use.
The vaccine should be injected subcutaneously through an area of clean, dry skin PRESENTATION
with precautions taken against contamination. The chest wall behind the shoulder or Raksha - Monovalent FMD Vaccine is available in polypropylene vials of 30 ml (15
the dewlap are the recommended sites for inoculation. Cattle doses and 30 Sheep doses), 100 ml (50 cattle doses and 100 sheep doses)
and 200 ml (100 cattle doses and 200 Sheep doses) .
DOSAGE
Cattle, Buffaloes and Calves : 2 ml CAUTION
Sheep and Goats : 1 ml Raksha Monovalent FMD vaccine is thoroughly tested before issue. As subsequent
handling and administration are not controlled by the manufacturers or distributors/
VACCINATION REGIMEN stockists, no responsibility following their use can be accepted. Raksha Monovalent
Primary vaccination : 4 months of age (Cattle, Buffaloes, Sheep and Goats). FMD vaccine is issued subject to this condition. Under field conditions it is extremely
Revaccination : Every 6 months thereafter. difficult to avoid the accidental introduction of bacteria when withdrawing doses of
Primovaccinates irrespective of age should receive two doses initially. This should be Raksha Monovalent FMD vaccine from the containers. Part-used bottles of vaccine
followed by every 6 months thereafter. should therefore be discarded at the end of the day’s operations.

SIDE EFFECTS Aqueous or Oil adjuvant vaccines, monovalent, bivalent, trivalent, quadrivalent
Generally no significant side effects are noticed after vaccination. However, in a few or any other valency incorporating the most relevant strains of epidemiological
cases a small swelling may develop at the site of inoculation, which usually subsides significance can be manufactured as per customer’s choice.

Raksha Bivalent
(FOOT AND MOUTH DISEASE VACCINE BP (Vet.))
Raksha FMD (Foot and Mouth Disease) vaccine is recommended for prophylactic
vaccination against Foot and Mouth Disease in cattle, buffaloes, sheep and goats.
Raksha FMD vaccine is manufactured by Indian Immunologicals with the process
know-how obtained from the Wellcome Foundation Ltd. U.K., the pioneers and world
leaders in FMD research, control and vaccine production.
COMPOSITION
Raksha Bivalent FMD vaccine contains tissue culture inactivated FMD virus strain O
and A (bivalent) adsorbed on Aluminium hydroxide and Saponin added as an adjuvant.
ADMINISTRATION
The vaccine vial should be kept cold until used and each vial should be well shaken
before contents are withdrawn. Syringes and needles must be sterilized before use.
The vaccine should be injected subcutaneously through an area of clean, dry skin
with precautions taken against contamination. The chest wall behind the shoulder or
the dewlap are the recommended sites for inoculation.
DOSAGE Cattle, Buffaloes and Calves : 3 ml
Sheep and Goats : 1 ml
VACCINATION REGIMEN
Primary vaccination : 4 months of age (Cattle, Buffaloes, Sheep and Goats).
Revaccination : Every 6 months thereafter.
Primovaccinates irrespective of age should receive two doses initially. This should be
followed by every 6 months thereafter.
SIDE EFFECTS
Generally no significant side effects are noticed after vaccination. However, in a few
cases a small swelling may develop at the site of inoculation, which usually subsides
within a few days. The body temperature generally remains normal.
BACK
TO
PRODUCT
RANGE
STORAGE AND TRANSPORT
The vaccine should be stored and transported between 2°C and 8°C. Antigenicity of
the vaccine deteriorates if the temperature is allowed to rise above this range, the
rate of deterioration depending on both temperature and time. At no stage should the
vaccine be frozen.
PRESENTATION
Raksha Bivalent FMD vaccine is available in 300ml bottles.
CAUTION
Raksha Bivalent FMD vaccine is thoroughly tested before issue. As subsequent
handling and administration are not controlled by the manufacturers or distributors/
stockists, no responsibility following their use can be accepted. Raksha Bivalent FMD
vaccine is issued subject to this condition. Under field conditions it is extremely difficult
to avoid the accidental introduction of bacteria when withdrawing doses of Raksha
Bivalent FMD vaccine from the containers. Part-used bottles of vaccine should therefore
be discarded at the end of the day’s operations.
Aqueous or Oil adjuvant vaccines, monovalent, bivalent, trivalent, quadrivalent
or any other valency incorporating the most relevant strains of epidemiological
significance can be manufactured as per customer’s choice.
 BACK
TO

Raksha Trivalent PRODUCT

RANGE

(FOOT AND MOUTH DISEASE VACCINE BP (Vet))

Raksha Trivalent FMD (Foot and Mouth Disease) vaccine is recommended for
prophylactic vaccination against Foot and Mouth Disease in cattle, buffaloes, sheep
and goats.
SIDE EFFECTS
Raksha FMD vaccine is manufactured by Indian Immunologicals with the process Generally no significant side effects are noticed after vaccination. However, in a few
know-how obtained from the Wellcome Foundation Ltd. U.K., the pioneers and world cases a small swelling may develop at the site of inoculation, which usually subsides
leaders in FMD research, control and vaccine production. within a few days. The body temperature generally remains normal.

COMPOSITION STORAGE AND TRANSPORT

Raksha Trivalent FMD vaccine contains tissue culture inactivated FMD virus strains The vaccine should be stored and transported between 2°C and 8°C. Antigenicity of
O, A and Asia-1 adsorbed on Aluminium hydroxide and Saponin added as an adjuvant. the vaccine deteriorates if the temperature is allowed to rise above this range, the
rate of deterioration depending on both temperature and time. At no stage should the
ADMINISTRATION vaccine be frozen.
The vaccine vial should be kept cold until used and each vial should be well shaken
before contents are withdrawn. Syringes and needles must be sterilized before use. PRESENTATION
The vaccine should be injected subcutaneously through an area of clean, dry skin Raksha Trivalent FMD vaccine is available in 300 ml polypropylene bottles.
with precautions taken against contamination. The chest wall behind the shoulder or
the dewlap are the recommended sites for inoculation. CAUTION
Raksha Trivalent FMD vaccine is thoroughly tested before issue. As subsequent
DOSAGE handling and administration are not controlled by the manufacturers or distributors/
Cattle, Buffaloes and Calves : 3 ml stockists, no responsibility following their use can be accepted. Raksha Trivalent FMD
Sheep and Goats : 1 ml vaccine is issued subject to this condition. Under field conditions it is extremely difficult
to avoid the accidental introduction of bacteria when withdrawing doses of Raksha
VACCINATION REGIMEN Trivalent FMD vaccine from the containers. Part-used bottles of vaccine should therefore
Primary vaccination : 4 months of age. be discarded at the end of the day’s operations.
Booster : 2 to 4 weeks after primary vaccination.
Revaccination : Every 6 months thereafter. Aqueous or Oil adjuvant vaccines, monovalent, bivalent, trivalent, quadrivalent
Primovaccinates irrespective of age should receive two doses initially. This should be or any other valency incorporating the most relevant strains of epidemiological
followed by every 6 months thereafter. significance can be manufactured as per customer’s choice.
 BACK
TO

Raksha-Ovac PRODUCT
RANGE

(FOOT AND MOUTH DISEASE OIL ADJUVANT VACCINE BP (Vet))

Raksha - Ovac (FMD Oil Adjuvant vaccine) is a unique Double Emulsion Oil Adju-
vant Vaccine and is recommended for prophylactic vaccination against Foot and Mouth
Disease in cattle, buffaloes, sheep, goats and pigs.

COMPOSITION
Raksha FMD Oil Adjuvant vaccine contains tissue culture virus strains O, A, C and
Asia-1 and inactivated with Aziridine compound. Mineral oil is added as an adjuvant.
into humans can produce serious localised reactions and special care should be taken
ADMINISTRATION to avoid accidental inoculation. If it happens, medical attention should be sought at
The vaccine vial should be kept cold until used and each vial should be well shaken once.
before contents are withdrawn. Syringes and needles must be sterilized before use.
The vaccine should be injected subcutaneously or intramuscularly through an area of STORAGE AND TRANSPORT
clean, dry skin with precautions taken against contamination. The vaccine should be stored and transported between 2°C and 8°C. Antigenicity of
the vaccine deteriorates if the temperature is allowed to rise above this range, the
DOSAGE rate of deterioration depending on both temperature and time. At no stage should the
Cattle, Buffaloes, Calves and Pigs : 2 ml vaccine be frozen.
Sheep and Goats : 1 ml
PRESENTATION
VACCINATION REGIMEN Raksha - OVAC vaccine is available in multiple dose bottles of 30 ml (15 doses) and
Primary vaccination : 4 months of age (Cattle, Buffaloes, Sheep and Goats). 100 ml (50 doses) Packs.
Primary vaccination : 2 months of age (Pigs).
Booster : 9 months after primary vaccination (Cattle/buffaloes/Sheep CAUTION
and Goats). Raksha - OVAC is thoroughly tested before issue. As subsequent handling and
Revaccination : Every 12 months thereafter (Cattle, Buffaloes, Sheep and administration are not controlled by the manufacturers or distributors/stockists, no
Goats). responsibility following their use can be accepted. Raksha - OVAC is issued subject
Revaccination : Every 6 months thereafter (Pigs). to this condition. Under field conditions it is extremely difficult to avoid the accidental
introduction of bacteria when withdrawing doses of Raksha - OVAC from the
SIDE EFFECTS containers. Part-used bottles of vaccine should therefore be discarded at the end of
As with all vaccines, hypersensitivity may occasionally occur. Adrenalin is the appro- the day’s operations.
priate treatment. However, treatment is seldom required and spontaneous recovery
generally follows rapidly. In case of food animals local carcass blemish at the site of FMD Oil adjuvant vaccines of monovalent, bivalent, trivalent, quadrivalent or
intramuscular injection may necessitate slight trimming of the carcass. This can be any other valency incorporating the most relevant strains of epidemiological
minimized by vaccinating at least two months before slaughter. Injection of mineral oil significance can be manufactured as per customer’s choice.

Raksha-Ovac Monovalent
(MONOVALENT FOOT AND MOUTH DISEASE OIL ADJUVANT VACCINE BP (Vet))
Raksha - Ovac (FMD Oil Adjuvant vaccine) is a unique Double Emulsion Oil Adjuvant
Vaccine and is recommended for prophylactic vaccination against Foot and Mouth
Disease in cattle, buffaloes, sheep, goats and pigs.
COMPOSITION
Raksha Ovac Monovalent FMD Oil Adjuvant vaccine contains tissue culture virus
strain O (Monovalent) and inactivated with Aziridine compound. Mineral oil is added
as an adjuvant.
ADMINISTRATION
The vaccine vial should be kept cold until used and each vial should be well shaken
before contents are withdrawn. Syringes and needles must be sterilized before use.
The vaccine should be injected subcutaneously or intramuscularly through an area of
clean, dry skin with precautions taken against contamination.
DOSAGE
Cattle, Buffaloes, Calves, Pigs : 2 ml
Sheep and Goats : 1 ml
VACCINATION REGIMEN
Primary vaccination : 4 months of age (Cattle, Buffaloes, Sheep and Goats).
Primary vaccination : 2 months of age (Pigs).
Booster : 9 months after primary vaccination (Cattle/buffaloes/Sheep
and Goats).
Revaccination : Every 12 months thereafter (Cattle, Buffaloes, Sheep and
Goats).
Revaccination : Every 6 months thereafter (Pigs).
SIDE EFFECTS
As with all vaccines, hypersensitivity may occasionally occur. Adrenalin is the
appropriate treatment. However, treatment is seldom required and spontaneous
recovery generally follows rapidly. In case of food animals local carcass blemish at
the site of intramuscular injection may necessitate slight trimming of the carcass. This
can be minimized by vaccinating at least two months before slaughter. Injection of
BACK
TO
PRODUCT
RANGE
mineral oil into humans can produce serious localised reactions and special care
should be taken to avoid accidental inoculation. If it happens, medical attention should
be sought at once.
STORAGE AND TRANSPORT
The vaccine should be stored and transported between 2°C and 8°C. Antigenicity of
the vaccine deteriorates if the temperature is allowed to rise above this range, the
rate of deterioration depending on both temperature and time. At no stage should the
vaccine be frozen.
PRESENTATION
Raksha Ovac Monovalent vaccine is available in 30 ml, 50 ml & 100 ml (50 dose)
vials.
CAUTION
Raksha Ovac Monovalent is thoroughly tested before issue. As subsequent handling
and administration are not controlled by the manufacturers or distributors/stockists,
no responsibility following their use can be accepted. Raksha Ovac Monovalent is
issued subject to this condition. Under field conditions it is extremely difficult to avoid
the accidental introduction of bacteria when withdrawing doses of Raksha Ovac
Monovalent from the containers. Part-used bottles of vaccine should therefore be
discarded at the end of the day’s operations.
SHELF LIFE
24 months.
FMD Oil adjuvant vaccines of monovalent, bivalent, trivalent, quadrivalent or
any other combination incorporating the most relevant strains of epidemiological
significance can be manufactured as per customer’s choice.
 BACK
TO

Raksha-Ovac Bivalent PRODUCT

RANGE

(FOOT AND MOUTH DISEASE OIL ADJUVANT VACCINE BP (Vet))

Raksha - Ovac (FMD Oil Adjuvant vaccine) is a unique Double Emulsion Oil Adjuvant
Vaccine and is recommended for prophylactic vaccination against Foot and Mouth
Disease in cattle, buffaloes, sheep, goats and pigs.

COMPOSITION be minimized by vaccinating at least two months before slaughter. Injection of mineral
Raksha Ovac Bivalent FMD Oil Adjuvant vaccine contains tissue culture virus strain oil into humans can produce serious localised reactions and special care should be
O and A (Bivalent) and inactivated with Aziridine compound. Mineral oil is added as taken to avoid accidental inoculation. If it happens, medical attention should be sought
an adjuvant. at once.

ADMINISTRATION STORAGE AND TRANSPORT

The vaccine vial should be kept cold until used and each vial should be well shaken The vaccine should be stored and transported between 2°C and 8°C. Antigenicity of
before contents are withdrawn. Syringes and needles must be sterilized before use. the vaccine deteriorates if the temperature is allowed to rise above this range, the
The vaccine should be injected subcutaneously or intramuscularly through an area of rate of deterioration depending on both temperature and time. At no stage should the
clean, dry skin with precautions taken against contamination. vaccine be frozen.

DOSAGE PRESENTATION
Cattle, Buffaloes, Calves, Pigs : 2 ml Raksha Ovac Bivalent vaccine is available in 30 ml, 100 ml (50 dose) vials.
Sheep and Goats : 1 ml
CAUTION
VACCINATION REGIMEN Raksha Ovac Bivalent is thoroughly tested before issue. As subsequent handling and
Primary vaccination : 4 months of age (Cattle, Buffaloes, Sheep and Goats). administration are not controlled by the manufacturers or distributors/stockists, no
Primary vaccination : 2 months of age (Pigs). responsibility following their use can be accepted. Raksha Ovac Bivalent is issued
Booster : 9 months after primary vaccination (Cattle/buffaloes/Sheep subject to this condition. Under field conditions it is extremely difficult to avoid the
and Goats). accidental introduction of bacteria when withdrawing doses of Raksha Ovac Bivalent
Revaccination : Every 12 months thereafter (Cattle, Buffaloes, Sheep and from the containers. Part-used bottles of vaccine should therefore be discarded at the
Goats). end of the day’s operations.
Revaccination : Every 6 months thereafter (Pigs).
SHELF LIFE
SIDE EFFECTS 24 months.
As with all vaccines, hypersensitivity may occasionally occur. Adrenalin is the
appropriate treatment. However, treatment is seldom required and spontaneous FMD Oil adjuvant vaccines of monovalent, bivalent, trivalent, quadrivalent or
recovery generally follows rapidly. In case of food animals local carcass blemish at the any other combination incorporating the most relevant strains of epidemiological
site of intramuscular injection may necessitate slight trimming of the carcass. This can significance can be manufactured as per customer’s choice.
 BACK
TO

Raksha-Ovac Trivalent PRODUCT

RANGE

(FOOT AND MOUTH DISEASE OIL ADJUVANT VACCINE BP (Vet))

Raksha - Ovac (FMD Oil Adjuvant vaccine) is a unique Double Emulsion Oil Adjuvant
Vaccine and is recommended for prophylactic vaccination against Foot and Mouth
Disease in cattle, buffaloes, sheep, goats and pigs.

COMPOSITION
Raksha - Ovac Trivalent (FMD Oil Adjuvant vaccine) contains tissue culture virus strains,
O, A, Asia-1, and inactivated with Aziridine compound. Mineral oil is added as an
adjuvant. be minimized by vaccinating at least two months before slaughter. Injection of mineral
oil into humans can produce serious localised reactions and special care should be
ADMINISTRATION taken to avoid accidental inoculation. If it happens, medical attention should be sought
The vaccine vial should be kept cold until used and each vial should be well shaken at once.
before contents are withdrawn. Syringes and needles must be sterilized before use.
The vaccine should be injected subcutaneously or intramuscularly through an area of STORAGE AND TRANSPORT
clean, dry skin with precautions taken against contamination. The vaccine should be stored and transported between 2oC and 8°C. Antigenicity of
the vaccine deteriorates if the temperature is allowed to rise above this range, the
DOSAGE rate of deterioration depending on both temperature and time. At no stage should the
Cattle, Buffaloes, Calves and Pigs : 2 ml vaccine be frozen.
Sheep and Goats : 1 ml
PRESENTATION
VACCINATION REGIMEN Raksha - Ovac Trivalent vaccine is available in 100 ml Packs.
Primary vaccination : 4 months of age (Cattle, Buffaloes, Sheep and Goats).
Primary vaccination : 2 months of age (Pigs). CAUTION
Booster : 9 months after primary vaccination (Cattle/buffaloes/Sheep Raksha - Ovac Trivalent is thoroughly tested before issue. As subsequent handling
and Goats). and administration are not controlled by the manufacturers or distributors/stockists,
Revaccination : Every 12 months thereafter (Cattle, Buffaloes, Sheep and no responsibility following their use can be accepted. Raksha - Ovac Trivalent is issued
Goats). subject to this condition. Under field conditions it is extremely difficult to avoid the
Revaccination : Every 6 months thereafter (Pigs). accidental introduction of bacteria when withdrawing doses of Raksha - Ovac Trivalent
from the containers. Part-used bottles of vaccine should therefore be discarded at the
SIDE EFFECTS end of the day’s operations.
As with all vaccines, hypersensitivity may occasionally occur. Adrenalin is the
appropriate treatment. However, treatment is seldom required and spontaneous FMD Oil adjuvant vaccines of monovalent, bivalent, trivalent, quadrivalent or
recovery generally follows rapidly. In case of food animals local carcass blemish at the any other valency incorporating the most relevant strains of epidemiological
site of intramuscular injection may necessitate slight trimming of the carcass. This can significance can be manufactured as per customer’s choice.
 BACK
TO

Raksha Biovac PRODUCT

RANGE

(FOOT AND MOUTH DISEASE + HAEMORRHAGIC SEPTICAEMIA VACCINE)

Raksha - Biovac (FMD + HS Oil adjuvant vaccine) is a unique Double Emulsion Oil
Adjuvant Vaccine and is recommended for prophylactic vaccination against Foot and
Mouth Disease & Haemorrhagic Septicaemia in cattle, buffaloes.

COMPOSITION
Raksha Biovac FMD Oil Adjuvant vaccine contains FMD virus inactivated antigens
against strains ''O, A and Asia - 1'' (inactivated with Aziridine compound) and inacti-
vated Pasteurella multocida culture (inactivated with Formaldehyde). Mineral oil is
added as an adjuvant. Thiomersal 0.01% W/V added as preservative.

ADMINISTRATION
The vaccine vial should be kept cold until used and each vial should be well shaken
before contents are withdrawn. Syringes and needles must be sterilized before use.
The vaccine should be injected intramuscularly through an area of clean, dry skin with
precautions taken against contamination, at mid neck region. administration are not controlled by the manufacturers or distributors/stockists, no
responsibility following their use can be accepted. Raksha Biovac is issued subject to
Directions Cattle / Buffaloes / Calves this condition. Under field conditions it is extremely difficult to avoid the accidental
Dosage 3ml introduction of bacteria when withdrawing doses of Raksha Biovac from the
Primary vaccination (PV) 4 months of age containers. Part-used bottles of vaccine should therefore be discarded at the end of
Booster / First revaccination 9 months after PV the day's operations. Injection of mineral oil into humans can produce serious
Revaccination Annual localized reactions and special care should be taken to avoid accidental inoculation.
If it happens, medical attention should be sought at once.
SIDE EFFECTS
Generally no significant side effects are noticed after vaccination. However, in a few NOT FOR HUMAN USE. FOR ANIMAL TREATMENT ONLY
cases small swelling may develop at the site of inoculation which usually subsides
within a few days. The body temperature remains normal. In rare cases hypersensi- STORAGE AND TRANSPORT
tivity may occur, immediate treatment with Antihistamine is advocated. Adrenalin is The vaccine should be stored and transported between 2oC and 8o C, Antigenicity of
the appropriate treatment. Accidental inoculation of oil vaccine by intravenous route the vaccine deteriorates if the temperature is allowed to rise above this range, the
results in allergic reaction. Anti-histamine is the choice of drug incase of such allergic rate of deterioration depending on both temperature and time.
reactions. At no stage should the vaccine be frozen.

CAUTION PRESENTATION
Raksha Biovac is thoroughly tested before issue. As subsequent handling and Raksha Biovac vaccine is available in 30ml polypropylene vials.
 BACK
TO

Raksharab PRODUCT
RANGE

(Rabies Veterinary Vaccine BP (Vet))

Raksharab is recommended for immunization of dogs and other domestic

animals against rabies for prophylactic use.

COMPOSITION
Raksharab Vaccine contains inactivated rabies virus with a potency > 1.0 I.U. per
dose. The virus is propagated in BHK-21 Cell line, inactivated with an aziridine
compound and concentrated. Aluminium hydroxide is added as an adjuvant.

ADMINISTRATION
1 ml. Subcutaneously / intramuscularly.

PROPHYLACTIC USE
Age - 3 months and above.

IMMUNITY STORAGE AND TRANSPORT

Immunity is conferred for 36 months. However, annual vaccination is recommended in Store and transport the vaccine between 2°C and 8°C till use. At no stage should the
endemic areas. vaccine be allowed to freeze.

PRECAUTIONS SHELF LIFE

Shake well before use. Vaccinate only healthy animals. Malnutrition, helminth infestation, 36 months from the date of manufacture, when stored at recommended storage
administration of immunosuppressive agents (like Corticosteroids, Radiation-therapy conditions.
etc.) will interfere with immune response to the vaccine.
PRESENTATION
POST VACCINATION REACTIONS Single dose vial : 1 ml
Generally no adverse reactions are noticed. Occasionally a transient, palpable nodule Multidose vial containing 5 doses : 5 ml
may occur at the site of injection. Multidose vial containing 10 doses : 10 ml
 BACK
TO

Raksha-SP PRODUCT
RANGE

(SHEEP POX CELL CULTURE VACCINE)

Raksha - SP (Sheep Pox) vaccine is recommended for prophylactic vaccination against

Sheep Pox sheep.

COMPOSITION
Raksha - SP vaccine contains live attenuated sheep pox virus grown on primary lamb
testicle cell culture and freeze dried. The virus is comprised of “ Romanian “ strain
which is the most effective and superior strain.

ADMINISTRATION
The vaccine presented as a freeze dried preparation in vials. Vaccine diluent vials of
50 ml are supplied for reconstituting freeze dried material. Chill the diluent prior to
reconstitution. Transfer a small aliquot of chilled diluent to vials containing the
freeze-dried preparation. Mix well to ensure uniform suspension. Transfer the
suspension to considering diluent vial and mix well. Intramuscular injection at mid
neck or thigh region.

DOSAGE
Sheep : 1 ml reconstituted vaccine.

VACCINATION REGIMEN
Suitable age for vaccination is 3 months. SHELF LIFE
It is advisable to vaccinate after lambing season or during onset of breeding season. When stored between 2°C to 8°C, the vaccine retains its potency for a period of Two
years.
CAUTION
Not for human use. For animal treatment only. STORAGE AND TRANSPORT
Keep reconstituted vaccine on ice. The vaccine should be stored and transported between 2° and 8°C. The diluent should
Use reconstituted vaccine immediately. be stored in a cool and dark place.
Part use of vial and storing in deep freeze or refrigerator is not recommended.
Avoid vaccination of animals in advanced stage of pregnancy. PRESENTATION
In rare cases hypersensitivity may occur, immediate treatment with antihistaminics is Raksha - SP vaccine is available in 50 dose glass vials.
advocated. Diluent : 50 ml in polypropylene vials.
 BACK
TO

Raksha-HS PRODUCT
RANGE

( Haemorrhagic Septicaemia Vaccine )

Raksha-HS is recommended for prophylactic vaccination against Haemorrhagic

Septicaemia in cattle and buffaloes.

COMPOSITION
Raksha-HS vaccine contains formalin inactivated culture of Pasteurella multocida
adjuvanted with aluminium hydroxide.

ADMINISTRATION
The vaccine vial should be thoroughly shaken before its contents are withdrawn. Only
sterile syringes and needles should be used. The vaccine should be injected
subcutaneously through an area of clean dry skin, with all precautions taken against
contamination. The recommended site for inoculation is the chest wall behind the
shoulder or the dewlap.

DOSAGE
Cattle, Buffaloes, Calves and Sheep – 2 ml.

VACCINATION REGIMEN
Primary vaccination : 6months of age and above.
Revaccination : Annually.

POST VACCINATION REACTIONS

Generally no adverse reactions are noticed. A slight swelling may appear at the site of
inoculation, which disappears quickly.

STORAGE AND TRANSPORT

The vaccine should be stored and transported between 2°C and 8°C. Do not allow
the vaccine to freeze.

PRESENTATION
Raksha-HS vaccine is available in polypropylene vials of 50 doses (100 ml).
 BACK
TO

Raksha-BQ PRODUCT
RANGE

( Black Quarter Vaccine )

Raksha-BQ is recommended for prophylactic vaccination against Black Quarter in

cattle and buffaloes.

COMPOSITION
Raksha-BQ vaccine contains formalin treated culture of Clostridium chauvoei
adjuvanted with aluminium hydroxide gel.

ADMINISTRATION
The vaccine vial should be thoroughly shaken before its contents are withdrawn. Only
sterile syringes and needles should be used. The vaccine should be injected
subcutaneously through an area of clean dry skin, with all precautions taken against
contamination. The recommended site for inoculation is the chest wall behind the
shoulder or the dewlap.

DOSAGE
Cattle, Buffaloes and Calves - 2 ml.

VACCINATION REGIMEN
Primary vaccination : 6months of age and above.
Revaccination : Annually.

POST VACCINATION REACTIONS

Generally no adverse reactions are noticed. A slight swelling may appear at the site of
inoculation, which disappears quickly.

STORAGE AND TRANSPORT

The vaccine should be stored and transported between 2°C and 8°C. Do not allow
the vaccine to freeze.

PRESENTATION
Raksha-BQ vaccine is available in polypropylene vials of 50 doses (100 ml).
 BACK
TO

Raksha-HS+BQ PRODUCT
RANGE

( Haemorrhagic Septicaemia & Black Quarter Combined Vaccine )

Raksha-HS+BQ is recommended for prophylactic vaccination against Haemorrhagic

Septicaemia and Black Quarter in cattle and buffaloes.

COMPOSITION
Raksha-HS+BQ vaccine contains formalin inactivated cultures of Pasteurella multocida
and Clostridium chauvoei adjuvanted with aluminium hydroxide gel.

ADMINISTRATION
The vaccine vial should be thoroughly shaken before its contents are withdrawn. Only
sterile syringes and needles should be used. The vaccine should be injected
subcutaneously through an area of clean dry skin, with all precautions taken against
contamination. The recommended site for inoculation is the chest wall behind the
shoulder or the dewlap.

DOSAGE
Cattle, Buffaloes and Calves - 3 ml.

VACCINATION REGIMEN
Primary vaccination : 6months of age and above.
Revaccination : Annually.

POST VACCINATION REACTIONS

Generally no adverse reactions are noticed. A slight swelling may appear at the site of
inoculation, which disappears quickly.

STORAGE AND TRANSPORT

The vaccine should be stored and transported between 2°C and 8°C. Do not allow
the vaccine to freeze.

PRESENTATION
Raksha-HS+BQ vaccine is available in polypropylene vials of 30 doses (90 ml).
 BACK
TO

Rakshavac-T PRODUCT
RANGE

(THEILERIOSIS VACCINE)

RAKSHAVAC - T Vaccine is recommended for prophylactic vaccination against

Theileriosis caused by Theileria annulata in crossbred and exotic cattle.

DESCRIPTION
Rakshavac-T is meant for prevention of Theileriosis caused by Theileria annulata in
crossbred and exotic cattle. Rakshavac-T contains live schizonts grown in lymphoblast
cell culture, attenuated by prolonged in-vitro passage. Attenuated schizonts do not
produce the clinical disease. Immunised cattle can withstand the attack of infected
ticks for a period of three years. In areas where the vaccinated animals are constantly
exposed to tick bites, the immunity is constantly boosted and hence the immunity is
conferred for life time. Where the animals are maintained in tick free condition,
revaccination every 3 years is recommended.

ADMINISTRATION
Remove the vial from liquid nitrogen container and thaw the vaccine concentrate in
lukewarm (37oC) water. Transfer the thawed vaccine concentrate using a sterile needle
and syringe to the corresponding vaccine diluent vial and mix gently. The reconstituted
vaccine should be injected subcutaneously through an area f clean dry skin with CAUTION
precautions taken against contamination. The recommended site for inoculation is Generally no adverse reactions are noticed. A few of the vaccinated animals may
midneck region. develop mild pyrexia and slight enlargement of the nearest pre-scapular lymphnode
anytime from day 8 to day 20 post vaccination.
Vaccine Vaccine Reconstitued In rare cases hypersensitivity may occur, immediate treatment with antihistaminics is
Concentrate Diluent Vaccine Volume advocated.
5 Dose 13.0 ml 15.0 ml
TRANSPORT AND STORAGE
DOSAGE Vaccine concentrate should be transported and stored in liquid nitrogen. The vaccine
Cattle and Calves - 3.0 ml. diluent should be stored in a cool and dark place.

VACCINATION REGIMEN Reconstituted vaccine should be used immediately (with one hour) and should not be
Cattle and calves of 2 months age and above only should be vaccinated. Vaccination frozen for reuse.
of animals in advanced stage of pregnancy should be avoided.
PACKING
Immunity generally develops 6 weeks after vaccination. No other Vaccine should be Vaccine concentrate : Vials of 5 doses.
administered for a period of 8 weeks after Theileriosis Vaccine. Diluent : Vials of 13 ml
 BACK
TO

Raksha-Anthrax PRODUCT
RANGE

(ANTHRAX SPORE VACCINE LIVE)

Raksha - Anthrax vaccine is recommended for prophylactic vaccination against

Anthrax in cattle and sheep.

COMPOSITION
Raksha - Anthrax vaccine contains live spores of attenuated strain of Bacillus anthracis.
Each dose contains Bacillus anthracis 5 x 106 spores.

ADMINISTRATION
Syringes and needles must be sterilized before use. The vaccine should be injected
by the route of subcutaneous or intramuscular through an area of clean, dry skin with
precautions taken against contamination.

DOSAGE
Cattle and Sheep : 1 ml

VACCINATION REGIMEN
Primary vaccination : Vaccinate the animals Two weeks before grazing.
Booster dose : Annually.

SHELF LIFE
When stored between 2°C to 8°C, the vaccine retains its potency for a period of Three
years.

CONTRA INDICATIONS
Animals suffering from fever and those affected with intercurrent diseases should not
be vaccinated.

STORAGE AND TRANSPORT

The vaccine should be stored and transported between 2°C and 8°C.

PRESENTATION
Raksha - Anthrax vaccine is available in 50 ml (50 dose) polypropylene vials.
 BACK
TO

Bruvax PRODUCT
RANGE

(Brucella abortus (strain 19) vaccine, live IP (Vet))

Brucellosis is an infectious and contagious disease of zoonotic importance caused by

gram negative coccobacilli (Brucella abortus, melitensis, ovis, suis and canis). The
disease affects cattle, buffalo, pigs, sheep, goats, dogs, elk and occasionally horses.
The disease is characterized by abortion, retained placenta and to a lesser extent
orchitis and infection of accessory sex glands in males.

Bruvax is a freeze dried vaccine and is used for the prevention of brucellosis (conta-
gious abortion) in cattle. The vaccine contains live brucella abortus strain 19 bacteria.
ditions.
DESCRIPTION
Light yellow flakes containing live Brucella abortus strain 19 bacteria in freeze dried CONTRAINDICATIONS
powder. Each dose contains not less than 40 x 109 organisms. Male calves should not be vaccinated. Do not vaccinate pregnant animals.

RECONSTITUTION PRECAUTIONS
Chill the diluent prior to reconstitution. Transfer a small amount of chilled diluent to vial Keep the reconstituted vaccine on ice.
containing freeze dried preparation mix well to ensure uniform suspension. Transfer Use reconstituted vaccine immediately.
the suspension to diluent vial and mix well. Part use of the vial and restoring in deep freezer or refrigerator is not recommended.
Strictly not for human use.
DOSAGE Syringes, needles and gloves should be disinfected/sterilized after use.
Serologically negative female calves of age 4 to 8 months only should be vaccinated Keep the vaccine out of the reach of children.
with 2 ml of reconstituted vaccine.
ADVERSE REACTIONS
ADMINISTRATION Generally no adverse reactions are noticed. A slight swelling and mild rise in body
By subcutaneous route. temperature, which may appear and disappear quickly.
The vaccine may infect human beings, particularly after accidental inoculation. Any
STORAGE & TRANSPORTATION necessary treatment should begin without delay. It is advisable to use hand gloves
The vaccine must be stored and transported between 2 and 8°C. and plain protecting glasses for eyes while carrying out vaccination.

SHELF LIFE PRESENTATION

12 months from the date of manufacture, when stored at recommended storage con- Bruvax is available in 5 dose pack (freeze dried) along with 10 ml of sterile diluent.
 BACK
TO

Bruvax Rev 1 PRODUCT

RANGE

(BRUCELLA MELITENSIS (REV 1) VACCINE (LIVE) B.P. (VET)

Bruvax Rev1 is a freeze dried vaccine and is recommended for immunization against
Brucellosis (contagious abortion) in sheep and goats.

DESCRIPTION
Bruvax Rev1, a freeze dried vaccine contains live Brucella melitensis Rev.1 strain
bacteria. Light yellow flake containing live Brucella melitensis Rev.1 strain bacteria in
lyophilized form. Each dose of vaccine contains 0.5 - 4 x 109 live organism as per B.P
(Vet).
ADMINISTRATION
The vaccine is recommended for sheep and goat @ 4 - 6 months of age, should be
vaccinated with 1 ml of reconstituted vaccine by subcutaneous route.
TRANSPORT AND STORAGE
The lyophilized vaccine must be transported and stored at 20C to 80C.
RECONSTITUTION AND METHOD OF ADMINISTRATION
The lyophilized vaccine should be reconstituted with chilled diluent provided with this
vaccine. Mix the vaccine properly in the diluent vial before inoculation. After thorough
mixing, the vaccine must be inoculated subcutaneously using sterile syringe and
separate sterile needle for each animal. The used vial should not be stored for future
use.
only. Keep the reconstituted vaccine in ice. Use reconstituted vaccine immediately.
Part use of the vial and restoring in deep freezer or refrigerator is not recommended.
PRECAUTIONS
Brucella melitensis Rev.1 vaccine has zoonotic importance. Hence it should be handled
with proper care to avoid accidental inoculation/inhalation/consumption. The used
vials along with syringe, needles and gloves must be decontaminated with
disinfectant before disposal. Keep the vaccine out of the reach of children. The
vaccine may infect human beings, particularly after accidental inoculation. Any
necessary treatment should begin without delay. It is advisable to use hand gloves
and plain protecting glasses for eyes while carrying out vaccination.
SHELF LIFE
12 months from the date of preparation when stored at recommended storage condi-
tions (between 2oC to 8oC).

DOSAGE PACKAGING
1ml subcutaneously at mid neck region. Available as 5 dose, 10 dose, 20 dose, & 100 dose pack along with 5ml, 10ml, 20ml
& 100ml sterile diluent.
ADVERSE REACTION
No adverse reaction should occur following inoculation if used as directed. A single DISTRUCTION OF USED CONTAINERS
injection should offer life long immunity, but the vaccine does not afford absolute The empty containers of the vaccine, used syringes and needles should be discarded
immunity in all animals. properly and carefully

CONTRAINDICATIONS / WARNINGS CAUTION

Do not vaccinate the pregnant animals. Strictly not for human use. For veterinary use For veterinary use only.
 BACK
TO

Raksha-ET PRODUCT
RANGE

(Enterotoxaemia Vaccine)

Raksha-ET is recommended for prophylactic vaccination against Enterotoxaemia in

sheep and goats.

COMPOSITION
Raksha-ET vaccine contains inactivated culture of anaerobically grown Clostridium
Welchii Type – D organisms. The prototoxin is converted into toxin by trypsinization.
The toxin is then rendered non-toxic by formalisation. This is then adjuvanted with
aluminium hydroxide gel.

ADMINISTRATION
The vaccine vial should be thoroughly shaken before its contents are withdrawn. Only
sterile syringes and needles should be used. The vaccine should be injected
subcutaneously through an area of clean dry skin, with all precautions taken against
contamination.

DOSAGE
Sheep and Goats - 2 ml.

VACCINATION REGIMEN
Primary vaccination : 4 months of age and above.
Revaccination : Annually.

POST VACCINATION REACTIONS

Generally no adverse reactions are noticed. A slight swelling may appear at the site
of inoculation, which disappears quickly.

STORAGE AND TRANSPORT

The vaccine should be stored and transported between 2°C and 8°C. Do not allow
the vaccine to freeze.

PRESENTATION
Raksha-ET vaccine is available in polypropylene vials of 50 doses (100 ml).

Raksha PPR
PESTE DES PETITS RUMINANTS (LIVING) VACCINE
COMPOSITION
Raksha PPR (Live Attenuated) vaccine containing 103 TCID50virus per dose in freeze-
dried form.
DESCRIPTION
RAKSHA - PPR vaccine contains live attenuated Peste des petits ruminants virus
grown on Vero cell culture and freeze dried. The virus is comprised of ''Sungri 96''
strain which is the most effective and superior strain.
RAKSHA - PPR is recommended for the prophylactic vaccination against Peste des
petits ruminants in sheep & goats.
ADMINISTRATION
The vaccine is presented as freeze dried preparation in vials. Vaccine diluent vials of
25ml, 50ml & 100ml are supplied for reconstituting freeze dried material. Chill the
diluent prior to reconstitution. Draw two/five ml sterile diluent from sterile diluent vial
using sterile syringe and reconstitute with the freeze dried vial. Shake well till the
contents in the FD vials are completely dissolved. Draw the whole volume of
reconstituted mixture using sterile syringe and inject back into the sterile diluent vial,
shake gently to get virus suspension. Each ml of the reconstituted mixture contains
one immunogenic dose against PPR. The whole contents of the reconstituted
vaccine should be used immediately .
Subcutaneous injection at mid neck region is advocated through an area of clean dry
skin with all precautions taken. Sterile needles and syringes should be used for every
withdrawal.
DOSAGE
Sheep and Goat : 1 ml reconstituted vaccine.
VACCINATION REGIMEN
Suitable age for vaccination is 4 months.
CAUTION
- Weak, debilitated and infested animals should not be vaccinated.
BACK
TO
PRODUCT
RANGE
- Sheep & Goat should be dewormed prior to vaccination.
- Vaccination Should be completed at least one month prior to monsoons.
- Vaccination Should not be taken up in the areas of disease outbreak.
- Vaccination should be checked for cold chain before reconstitution & vaccination.
- Vaccination should be taken up only under the supervision of a registered veteri
nary practitioner.
- Keep reconstituted vaccine on ice.
- Use reconstituted vaccine immediately.
- Part use of vial and storing in deep freeze or refrigerator is not recommended .
- Fresh sterilized disposable needles are to be used for every sheep & goat to avoid
cross contamination.
- A maximum of 10 withdrawals should be made from reconstituted vaccine.
- Vaccination of animals in advanced stage of pregnancy is not recommended.
- In rare cases hypersensitivity may occur, immediate treatment with antihistaminic
is advocated.
Post vaccination reaction:
Generally no adverse reactions are noticed.
A few of vaccinated animals might show pyrexia and transient drop in milk yield.
Vaccination could precipitate pre-incubating diseases in rare cases.
Transportation and storage:
The vaccine should be transported at 2oC - 8oC upon arrival should be stored at
-20oC.
The diluent should be stored in a cool and dark place.
PRESENTATION
Raksha - PPR vaccine is available in 25, 50 & 100 dose glass vials. Diluent: 25ml,
50ml, & 100ml in polypropylene vials.
 BACK
TO

Raksharab PRODUCT
RANGE

(Rabies Veterinary Vaccine BP (Vet))

Raksharab is recommended for immunization of dogs and other domestic

animals against rabies for prophylactic use.

COMPOSITION
Raksharab Vaccine contains inactivated rabies virus with a potency > 1.0 I.U. per
dose. The virus is propagated in BHK-21 Cell line, inactivated with an aziridine
compound and concentrated. Aluminium hydroxide is added as an adjuvant.

ADMINISTRATION
1 ml. Subcutaneously / intramuscularly.

PROPHYLACTIC USE
Age - 3 months and above.

IMMUNITY STORAGE AND TRANSPORT

Immunity is conferred for 36 months. However, annual vaccination is recommended in Store and transport the vaccine between 2°C and 8°C till use. At no stage should the
endemic areas. vaccine be allowed to freeze.

PRECAUTIONS SHELF LIFE

Shake well before use. Vaccinate only healthy animals. Malnutrition, helminth infestation, 36 months from the date of manufacture, when stored at recommended storage
administration of immunosuppressive agents (like Corticosteroids, Radiation-therapy conditions.
etc.) will interfere with immune response to the vaccine.
PRESENTATION
POST VACCINATION REACTIONS Single dose vial : 1 ml
Generally no adverse reactions are noticed. Occasionally a transient, palpable nodule Multidose vial containing 5 doses : 5 ml
may occur at the site of injection. Multidose vial containing 10 doses : 10 ml

Megavac-6
COMPOSITION
Megavac - 6 contains : Distemper*, Hepatitis (CAV2)*, Parvovirus*, Hepatitis (CAV1)
,
Leptospira canicola
, Leptospira icterohaemorrhagiae
.
* : Live Attenuated viruses

: Inactivated antigens
The above canine vaccine contain the following live attenuated viruses and / or
inactivated antigens.
FEEZE DRIED VACCINES - LIVE
Canine Distemper
Live attenuated vaccine strain of canine distemper virus is grown on a continuous cell
line and presented in a freeze dried form. Each dose contains > 103 TCID50 live
attenuated canine distemper virus. Continuous passage of the virus through tissue
culture resulted in a highly attenuated virus vaccine of high purity, completely
homogeneous and without side effects on susceptible pups. The safety of the vaccine
is confirmed by intracerebral injection into susceptible pups and mice.
Canine Contagious Hepatitis
Live canine adenovirus type-2 (CAV-2) virus, causative organism of infectious
laryngotracheitis is grown on a continuous cell line and presented in a freeze dried
form. Each dose contains > 103 TCID50 live attenuated CAV-2. The complete safety of
CAV-2 strain and the total cross immunity properties with CAV-1, responsible agent
for canine contagious hepatitis, has led to this choice for hepatitis vaccine. The safety
of vaccine is confirmed by intravenous injection into sensitive pups.
Canine Parvovirus
Live attenuated canine parvovirus is grown on a continuous cell line and presented in
a freeze dried form. Each dose contains > 103 TCID50 live attenuated canine parvovirus.
Parvovirus strain of canine origin is attenuated by continuous passages on cell cultures.
The safety of this vaccine is determined by testing on susceptible pups and bitches at
different stages of pregnancy.
BACK
TO
PRODUCT
RANGE
The potency of canine parvovirus is tested by injecting into seronegative pups and
antibodies are checked by haemagglutination inhibition (HI) test and by virulent
challenge of the dogs after a single injection of vaccine. Vaccinated dogs showed no
clinical or haematological symptoms. No virus excretion was observed in the faeces.
Megavac-P can be used to immunize puppies with low titres of maternal antibodies.
AQUEOUS VACCINES - INACTIVATED
Canine contagious Hepatitis
Canine contagious hepatitis virus (canine adenovirus type-1) is grown on a continuous
cell line and inactivated in such a manner that the virus loses its infectivity and retains
its immunogenicity.
Leptospirosis
Leptospira canicola and Leptospira icterohaemorrhagiae are grown in a suitable
medium and inactivated in such a manner that the culture loses its infectivity and
retains its immunogenicity. The inactivated antigen incorporated in the vaccine contains
> 2 x 108 bacteria each. The strains of leptospira used to produce this vaccine are free
from any pathogenic activity on any species. The somatic antigens are purified and
concentrated by ultrafiltration. The antigens are inactivated by formaldehyde, and are
purified at the end of inactivation and hence the final vaccine does not contain any
residual toxic material. The final potency and safety of vaccine is tested on hamsters
and dogs, which have to be resistant to challenge, proving fatal to the controls.
INDICATIONS
For the active immunization against Canine Distemper, Canine Contagious Hepatitis,
Canine Parvovirus disease, Leptospirosis.
ADMINISTRATION AND DOSAGE
1 ml intramuscularly or subcutaneously for the vaccine. Freeze dried vaccines may be
reconstituted with either aqueous vaccines or sterile diluent just before use. Shake
the reconstituted vaccines before use. Vaccine should be administered observing
aseptic precautions.
Continued
 BACK
TO
PRODUCT
RANGE

VACCINATION REGIMEN
First vaccination : 8 - 9 weeks of age
Second vaccination : 12 weeks of age
Revaccination : Yearly (annual)

IMMUNITY
Adequate immunity is established approximately 10 to 15 days after vaccination in
case of seronegative dogs. In case of pups containing maternal antibodies second
vaccination is advocated for complete protection. Immunity lasts for 1 to 2 years and
annual revaccinations are recommended for fool proof protection.
ADVERSE REACTIONS / CONTRAINDICATIONS
Dogs already sick and / or heavily infested with parasites should not be vaccinated.
Utmost care should be taken while vaccinating pregnant bitches. Dogs under
corticosteroid therapy should not be vaccinated. In rare cases hypersensivity may
occur, immediate treatment with antihistaminics is advocated. Use sterile material for
injection purpose
EFFECTS WITH OTHER VACCINES
Megavac-6 is safe and can be used with other commonly used vaccines.
OVERDOSE
Twice the dose is also very safe in target species
SHELF LIFE
24 months from the date of manufacture (when stored at recommended storage
temperature).
STORAGE AND TRANSPORT
Store and transport the vaccine between 2°C and 8°C till use. At no stage should the
vaccine be allowed to freeze.
PACKING INFORMATION
Megavac-6 is available in single dose packs. The vaccine is packed in glass vials. The
glass vials are sealed with rubber bungs, aluminium flip off seals and labeled with
corresponding labels. 25 doses are packed in a plastic tray / container. These trays
are packed in polystyrene boxes with two cool packs with an outer corrugated boxes
while transportation.

WITHDRAWAL PERIOD DISTRUCTION OF USED CONTAINERS

Not applicable The empty containers of the vaccine, used syringes and needles should be discarded
properly and carefully.
WARNINGS
The veterinarian who administer the vaccine should wash the hands before and after CAUTION
vaccination with soap followed by clean running water. For veterinary use only.
Back
 BACK
TO

Megavac-P (Inact.) PRODUCT

RANGE

(Canine Parvovirus vaccine inactivated (Vet))

COMPOSITION
Megavac - P (Inact.) vaccine contains tissue culture adapted strain of canine parvovirus OVERDOSE
grown on A-72 cell cultures and inactivated with ß-propiolactone. Aluminium hydroxide Twice the dose is also very safe in target species
gel is used as an adjuvant.
WITHDRAWAL PERIOD
INDICATIONS Not applicable
For the active immunization against Canine parvovirus disease.
WARNINGS
ADMINISTRATION AND DOSAGE The veterinarian who administers the vaccine should wash the hands before and
1 ml subcutaneously or intramuscularly per animal. Vaccine should be administered after vaccination with soap followed by clean running water.
observing aseptic precautions.
SHELF LIFE
VACCINATION REGIMEN 24 months from the date of manufacture (when stored at recommended storage
First vaccination :6 weeks of age. temperature).
Second vaccination :3 weeks apart till the age of 18 weeks.
Revaccination :Yearly (annual) STORAGE AND TRANSPORT
Store and transport the vaccine between 2°C and 8°C till use. At no stage should the
IMMUNITY vaccine be allowed to freeze.
Adequate immunity is established approximately 21-28 days after vaccination in case
of seronegative dogs. In case of pups containing maternal antibodies second PACKING INFORMATION
vaccination is advocated for complete protection. Immunity lasts for 1 to 2 years and Megavac-P (inact.) is available in single dose packs. The vaccine is packed in glass
annual revaccinations are recommended for foolproof protection. vials. The glass vials are sealed with rubber bungs, and flip off seals with the
corresponding labels. 10 doses are packed in a carton. These cartons are packed in
ADVERSE REACTIONS / CONTRAINDICATIONS polystyrene boxes with two cool packs with an outer corrugated box while
Dogs already sick and / or heavily infested with parasites should not be vaccinated. transportation.
Utmost care should be taken while vaccinating pregnant bitches. Dogs under
corticosteroid therapy should not be vaccinated. In rare cases hypersensivity may DISTRUCTION OF USED CONTAINERS
occur, immediate treatment with antihistaminics is advocated. Use sterile material for The empty containers of the vaccine, used syringes and needles should be discarded
injection purpose properly and carefully.

EFFECTS WITH OTHER VACCINES CAUTION

Megavac-P (inact.) is safe and can be used with other commonly used vaccines. For veterinary use only.
 BACK
TO

Megavac-CC PRODUCT
RANGE

(Canine Corona virus vaccine inactivated (Vet))

COMPOSITION OVERDOSE
Megavac-CC vaccine contains tissue culture adapted strain of Canine Corona virus Twice the dose is also very safe in target species.
grown on A-72 cell cultures and inactivated with ß-propiolactone. Aluminium hydroxide
gel is used as an adjuvant. WITHDRAWAL PERIOD
Not applicable
INDICATIONS
For the active immunization against Canine corona virus disease. WARNING
The veterinarian who administers the vaccine should wash the hands before and
ADMINISTRATION AND DOSAGE after vaccination with soap followed by clean running water.
1 ml subcutaneously or intramuscularly per animal. Vaccine should be administered
observing aseptic precautions. SHELF LIFE
24 months from the date of manufacture (when stored at recommended storage
VACCINATION REGIMEN temperature)
First vaccination :8-9 weeks of age
Second vaccination :12 weeks STORAGE AND TRANSPORT
Revaccination :Yearly booster is recommended. Store and transport the vaccine between 2°c to 8°c till use. At no stage should the
vaccine be allowed to freeze.
IMMUNITY
Adequate immunity is established approximately 10 - 15 days after vaccination in PACKING INFORMATION
case of seronegative dogs. In case of pups possessing maternal antibodies second Megavac - CC is available in single dose packs. The vaccine is packed in glass vials.
vaccination is advocated for complete protection. Immunity lasts for 1 to 2 years The glass vials are sealed with rubber bungs, aluminium seals and flip off seals with
and annual revaccinations are recommended. the corresponding labels. 10 doses are packed in a carton. These cartons are packed
in polystyrene boxes with two cool packs with an outer corrugated box while
ADVERSE REACTIONS / CONTRA INDICATIONS transportation.
Dogs already sick and/or heavily infected with parasites should not be vaccinated.
Utmost care should be taken while vaccinating pregnant bitches. Dogs under DISTRUCTION OF USED CONTAINERS
corticosteroid therapy should not be vaccinated. In rare cases hypersensitivity may The empty containers of the vaccine, used syringes and needles should be discarded
occur, immediate treatment with antihistaminics is advocated. properly and carefully.

EFFECTS WITH OTHER VACCINES CAUTION

Megavac – CC is safe and can be used with other commonly used vaccines. For veterinary use only.
 BACK
TO

Ivectin PRODUCT
RANGE

(Veterinary Injection 1 % W/V)

Ivermectin is a clear oil based injectable solution presented in colorless vials.

Ivermectin belongs to the group macrolides, an antibiotic produced by
actinomycetes micro-organisms. It is also known as macrocyclic lactones. It is
highly potent parasiticide which show great activity against a wide range of endo-
parasites and ecto-parasites. The dose requirements is so minute that it requires
only micrograms of drug as compared to milligrams of other drugs. This can be
administered orally or parenterally. It’s activity persists for along time. Ivermectin
has got a wide safety margin of >30 times the recommended dose in cattle.

COMPOSITION
Each ml contains Ivermectin 10 mg. Ivermectin is a mixture comprising of not less
than 80% 22, 23-dihydroavermectin Bla and not more than 20% 22, 23-
dihydroavermectin Blb .

ACTIVITY
Ivermectin is effective against all stages of most of the major parasites including
canine heartworm larvae. It is also a potent ectoparasiticide. Its mode of action
restricts its use against tapeworms and flukes. Ivermectin acts on the parasites by
effecting Gama Amino Butyric Acid (GABA) mediated signals between nerves and
muscles. Flukes and tapeworms (Platyhelminths) are known not to use GABA as a
neurotransmitter. Mammalian GABA –engic neurons occur in the central nervous DOSAGE
system and ivermectin dose not penetrate mammalian blood-brain barrier and Cattle : 1.0 ml / 50 Kg B.Wt. Subcutaneously.
hence it has low toxicity. The detailed activity against specific parasites in various Sheep : 0.5 ml / 25 Kg B.Wt. Subcutaneously.
hosts is mentioned in the table below. Pigs : 1.0 ml / 33 Kg B.Wt. Subcutaneously.
Dogs : 0.02 ml / Kg B.Wt. Subcutaneously (in case of heart worms 6 mcg/kg
METABOLISM once in 30 days).
Ivermectin is readily absorbed, especially when given parenterally. High
concentrations of drug are sustained in the tissues for long periods, after parenteral TOXICITY
administration. Drug residues occur mainly in the liver and fat with very little in the Ivermectin has a safety index of > 30 times the recommended dose in cattle. It
muscle. The bulk drug is excreted in the faeces (98%) with only 2% in the urine. should not be administered parenterally to horses, and is toxic in certain breeds of
A withdrawl period of 21 days (28 days for cattle) before slaughter is required dogs like collies. The relatively high brain concentration of drug in these animals is
because of the persisting levels of drug in tissues, and milk from dairy cattle due to genetic susceptibility to greater penetration of the blood brain barrier and
undergoing treatment with Ivermectin is not recommended for Human consumption. results in the toxicity.
Continued
 BACK
TO
PRODUCT
RANGE

ACTION OF IVERMECTIN (1% w/v INJECTABLE SOLUTION) IN VARIOUS ANIMALS

ANIMAL ADMINISTRATION DOSAGE PARASITES CONTROLLED

Cattle Subcutaneous 1.0 ml/50 kg body weight Hypoderma bovis, Hypoderma lineatum,
Dermatobia hominis, Haematopinus eurysternus,
Lonognathus vituli, Sarcoptes scabiei var bovis,
Boophilus microplus, Boophilus decoloratus,
Screw worms, Chrysomia bezziana,
Trichostrongylus axei, Haemonchus sps.,
Ostertagia sps., Ostertagia inhibited Larvae 4,
Trichostrongylus sps., Nematodirus sps., Cooperia
sps., Bunostomum sps., Strongyloides sps.,
Oesophagastomum sps, Chabertia sps., Trichuris
sps., Dictyocaulus sps.

Sheep Subcutaneous 0.5 ml/25 kg body weight Oestrus ovis, Sarcoptes scabiei, Psoregates var
ovis, Trichostrongylus axei, Haemonchus sps.,
Ostertagia sps., Ostertagia inhibited Larvae 4,
Trichostrongylus sps., Nematodirus sps., Cooperia
sps., Bunostomum sps., Strongyloides sps.,
Oesophagastomum sps., Chabertia sps.,
Chabertia sps., Trichuris sps., Dictyocaulus sps.

Pigs Subcutaneous 1.0 ml/33 kg body weight Haematopinus suis, Sarcoptes scabiei var suis,
Hyostrongylus rubidus, Ascaris suum,
Stongyloides ransomi, Oesophagastomum sps.,
Metastrongylus sps.
Withdrawal Period
Meat : 28 days, Milk : 28 days
Dogs Subcutaneous 0.02 ml / kg body weight Sarcoptes scabiei, Otodectes cynotis, Toxascaris
leonina, Toxocara caninum / cati, Uncinaria
Presentation
stenocephala, Ancylostoma caninum, Trichuris
The Ivectin Injection is available in 1 ml, 7 ml and 50
vulpis, Dirifilaria (larval stages)
ml packs.
Back
 BACK
TO

Vetalben PRODUCT
RANGE

(Albendazole Suspension U.S.P 2.5% w/v)

DESCRIPTION
A liquid suspension containing Albendazole.

COMPOSITION
Each ml contains Albendazole I.P. 25 mg.

INDICATIONS
A broad spectrum anthelmintic for treatment of gastrointestinal infestations due to
roundworms, lungworms, tapeworms, liverflukes and amphistomes. Albendazole also
has an ovicidal effect.

DOSAGE
FOR ROUNDWORMS / TAPEWORMS
All animals except Dog & Cat 5 mg per kg body weight. i.e. 2 ml per 10 kg. body weight
Dog and Cat 10 – 25 mg per kg. body weight i.e. 0.4 ml to 1 ml per
kg. body wt To be given in divided doses for 3 days

FOR FLUKES
Cattle / Buffalo 10 mg per kg body weight. i.e. 4 ml per 10 kg. body weight
WARNINGS
Sheep & Goat 7.5 mg per kg. body weight i.e. 3 ml per 10 kg. Animals intended for human consumption should not be slaughtered during the
body weight treatment. Milk from the animals which are under treatment with Vetalben should not
be used for human consumption. Before calculating the dosage, assess body weight
In all animals, repeating the treatment 3 weeks after first dose and there after every as accurately as possible.
two months, offers better control of worm infestation.
PRECAUTIONS
ADMINISTRATION Dispose the used containers safely. Keep the drug out of reach of children. Shake
By oral drenching. well before use. Wash hands after use. Protect from light and freezing. Store in cool
and dark place below 25°C. For veterinary use only.
WITHDRAWAL PERIOD
Meat : 14 days, Sheep : 10 days and Milk : 3 days PACK
Vetalben is available in 1 & 5 liter HDPE packs.
 BACK
TO

Vetalben 10% PRODUCT

RANGE

(Albendazole Suspension U.S.P 10 % w/v)

Description
A liquid suspension containing Albendazole.

Composition
Each ml contains Albendazole 100 mg.

Indications
A broad spectrum anthelmintic for treatment of gastrointestinal infestations due to
roundworms, lungworms, tapeworms, liverflukes and amphistomes. Albendazole also
has an ovicidal effect.

Dosage

FOR ROUNDWORMS / TAPEWORMS

All animals except Dog & Cat 5 mg per kg body weight. i.e. 1 ml per 20 kg.
body weight
Dog and Cat 10 - 25 mg per kg. body weight i.e. 1 ml to 2.5 ml
per 10 kg. body wt To be given in divided doses Withdrawal Period
for 3 days Meat : 14 days, Sheep : 10 days and Milk : 3 days

Warnings
FOR FLUKES Animals intended for human consumption should not be slaughtered during the
Cattle / Buffalo 10 mg per kg body weight. i.e. 1 ml per 10 kg. treatment. Milk from the animals which are under treatment with Vetalben should not
body weight be used for human consumption. Before calculating the dosage, assess body weight
as accurately as possible.
Sheep & Goat 7.5 mg per kg. body weight i.e.1.50 ml per 20 kg.
body weight Precautions
Dispose the used containers safely. Keep the drug out of reach of children. Shake
In all animals, repeating the treatment 3 weeks after first dose and there after every well before use. Wash hands after use. Protect from light and freezing. Store in cool
two months, offers better control of worm infestation. and dark place below 25°C. For veterinary use only.

Administration Pack
By oral drenching. Vetalben 10% is available in 1 & 5 liter HDPE packs.
 BACK
TO

Vetalben-T PRODUCT
RANGE

(Albendazole 150 mg tablets)

Vetalben - T (Albendazole 150 mg) is a broad spectrum anthelmintic for the treatment
of gastrointestinal infestations due to round worms, lungworms, tapeworms, liverflukes
and amphistomes.

DESCRIPTION
White to off white coloured tablet .

USES
A broad spectrum multi-purpose anthelmintic for control of following types of internal
parasites in cattle, sheep, and goats.
Round worms, Lungworms, Tapeworms, Liverflukes and Amphistomes.

DOSAGE AND ADMINISTRATION

Vetalben-T tablets are to be administered orally.

All Animals except Dogs and Cats

5 mg /kg body weight ( One tablet of Vetalben-T [Albendazole 150 mg] per 30 kg body
weight) against roundworms, lungworms and tapeworms.

Dogs and Cats

50 mg /kg body weight (One tablet of Vetalben-T [Albendazole 150 mg] per 3 kg body WITHDRAWL PERIOD
weight) against roundworms, lungworms and tapeworms. The milk from the animals (which underwent Vetalben-T treatment) is fit for human
consumption only after 72 hour post treatment.
CONTRA INDICATIONS The animals are fit for slaughter only after 14 days of post treatment.
When followed recommended dosage Vetalben-T is very safe in all species. However
over dosage (five times the recommended dosage) may lead to adverse reactions in STORAGE
the healthy animals. Store in a dark place.

Treat the pregnant animals only as per the dosage strictly. PRESENTATION
Each strip (blister pack) contains 10 tablets. 10 strips are packed in a carton (Each
Keep the tablets out of the reach of children. carton contains 100 tablets).
 BACK
TO

Vetalben-300 PRODUCT
RANGE

(Albendazole 300 mg tablets)

Vetalben 300 mg is a broad spectrum anthelmintic for the treatment of gastrointestinal

infestations due to round worms, lungworms, tapeworms, liverflukes and amphistomes.

DESCRIPTION
Deep green coloured Boli .

USES
A broad spectrum multi-purpose anthelmintic for control of following types of internal parasites
in cattle, sheep, and goats.
Round worms, Lungworms, Tapeworms, Liverflukes and Amphistomes.

DOSAGE AND ADMINISTRATION

Vetalben 300 mg tablets are to be administered orally.

Animals Gastrointestinal Chronic Acute Fascioliasis

round worms Fascioliasis due to due to Dircocoelium
lung worms F.hepatica dendriticum
tape worms
Cattle 1 bolus for 40 kg b.w 1 bolus for 30 kg b.w 2 boli for 40 kg b.w
Sheep & Goats ½ bolus for 40kg b.w 1 bolus for 40 kg b.w 2 boli for 40 kg b.w

CONTRA INDICATIONS
When followed recommended dosage Vetalben-300 is very safe in all species. However over
dosage (five times the recommended dosage) may lead to adverse reactions in the healthy
animals.
Treat the pregnant animals only as per the dosage strictly.
Keep the tablets out of the reach of children. STORAGE
Store in a dark place.
WITHDRAWL PERIOD
The milk from the animals (which underwent Vetalben-300 treatment) is fit for human PRESENTATION
consumption only after 72 hour post treatment. Each strip (blister pack) contains 5 boli. 10 strips are packed in a carton
The animals are fit for slaughter only after 14 days of post treatment. (Each carton contains 50 boli).
 BACK
TO

Vetalben-600 PRODUCT
RANGE

(Albendazole 600 mg bolus)

Vetalben 600 mg is a broad spectrum anthelmintic for the treatment of gastrointestinal infesta-
tions due to round worms, lungworms, tapeworms, liverflukes and amphistomes.

DESCRIPTION
Deep Green coloured bolus.

USES
A broad spectrum multi-purpose anthelmintic for control of following types of internal parasites
in cattle, sheep, and goats.
Round worms, Lungworms, Tapeworms, Liverflukes and Amphistomes.

DOSAGE AND ADMINISTRATION

Vetalben 600 mg tablets are to be administered orally.

Animals Gastrointestinal Chronic Acute Fascioliasis

Round worms Fascioliasis due to Dircocoelium
Lung worms F.hepatica dendriticum
Tape worms due to
Cattle 1/2 bolus for 40 kg b.w 1/2 bolus for 30 kg b.w 1 bolus for 40 kg b.w
Sheep & Goats ½ bolus for 40kg b.w 1/2 bolus for 40 kg b.w 1 bolus for 40 kg b.w

CONTRA INDICATIONS
When followed recommended dosage Vetalben-600 is very safe in all species. However over
dosage (five times the recommended dosage) may lead to adverse reactions in the healthy
animals.
Treat the pregnant animals only as per the dosage strictly. Care should be taken not to exceed
recommended dosage during the first month of pregnancy.
Keep the tablets out of the reach of children. STORAGE
Store in a dark place.
WITHDRAWL PERIOD
The milk from the animals (which underwent Vetalben-600 treatment) is fit for human consump- PRESENTATION
tion only after 72 hour post treatment. Each strip (blister pack) contains 5 boli. 10 strips are packed in a carton
The animals are fit for slaughter only after 14 days of post treatment. (Each carton contains 50 boli).
 BACK
TO

Vetalben-Forte PRODUCT
RANGE

(Albendazole 2500 mg bolus)

Vetalben-Forte is a broad spectrum anthelmintic for the treatment of gastrointestinal

infestations due to round worms, lungworms, tapeworms, liverflukes and amphistomes.

DESCRIPTION
Deep Green coloured bolus.

USES
A broad spectrum multi-purpose anthelmintic for control of following types of internal
parasites in cattle, sheep, and goats.

Round worms, Lungworms, Tapeworms, Liverflukes and Amphistomes.

DOSAGE AND ADMINISTRATION

Vetalben - Forte mg boli are to be administered orally.

Flukes 1 bolus / 250 Kg.B.wt

Roundworms & Tapeworms 1 bolus / 350 Kg.B.wt.

CONTRA INDICATIONS
When followed recommended dosage Vetalben-Forte is very safe in all species.
However over dosage (five times the recommended dosage) may lead to adverse
reactions in the healthy animals.

Cows during the first 45 days of pregnancy should not under go the treatment with
Vetalben-Forte.

Keep the tablets out of the reach of children.

STORAGE
WITHDRAWL PERIOD Store in a dark place.
The milk from the animals (which underwent Vetalben-Forte treatment) is fit for human
consumption only after 72 hour post treatment. PRESENTATION
Each strip (blister pack) contains 4 boli. 10 strips are packed in a carton (Each carton
The animals are fit for slaughter only after 21 days of post treatment. contains 40 boli).
 BACK
TO

Vetfen PRODUCT
RANGE

(Anthelmintic tablet & bolus)

A unique broad spectrum anthelmintic tablets for eradication of multi helminth

infestation, viz : Nematodes, Lungworms, and Tapeworms.

Composition
Each tablet of Vetfen - T contains Fenbendazole 150 mg.
Each bolus of Vetfen-B contains Fenbendazole 1.5 g
Each bolus of Vetfen-500 contains Fenbendazole 0.5 g

Indications
Infestation of gastrointestinal nematodes, lungworms and tapeworms viz. Haemonchus
spp., Ostertagia spp., Trichostrongylus spp., Metastrongylus spp., Cooperia spp.,
Nematodirus spp., Neoascaris vitulorum, Oesophagostomum spp., Chabertia spp.,
Bunostomum spp., Capillaria spp., Trichuris spp., Strongyloids spp., Hylostrongylus
rubidus, Ascaris suum, Dictyocaulus spp., Moniezia spp., etc in cattle, baffaloes, horses,
camels, sheep, goats, pigs, dogs and cats.

Vetfen also has ovicidal effect.

DOSAGE
For Roundworms / Tapeworms : To be administered orally @ 5 mg Fenbendazole /
kg body weight in all animals (except in dogs/cats) for roundworms infestation i.e. one
bolus of 1.5 g for 300 kg body weight. Or one tablet for 30 kg body weight in dogs and
cats, the basic dosage is 50 mg Fenbendazole / kg body weight to be given daily in
divided doses for 3 days.

Pack
Vetfen-T is available in strip of 10s, Vetfen-B in strip of 2s and
Vetfen-500 in strip of 4s.
 BACK
TO

Vetfen-B PRODUCT
RANGE

(Anthelmintic bolus)

Description
A unique broad spectrum anthelmintic tablets for eradication of multi helminth
infestation, viz : Nematodes, Lungworms, and Tapeworms.

Composition
Each bolus of Vetfen-B contains Fenbendazole 1.5 g

Indications
Infestation of gastrointestinal nematodes, lungworms and tapeworms viz. Haemonchus
spp., Ostertagia spp., Trichostrongylus spp., Metastrongylus spp., Cooperia spp.,
Nematodirus spp., Neoascaris vitulorum, Oesophagostomum spp., Chabertia spp.,
Bunostomum spp., Capillaria spp., Trichuris spp., Strongyloids spp., Hylostrongylus
rubidus, Ascaris suum, Dictyocaulus spp., Moniezia spp., etc in cattle, baffaloes, horses,
camels, sheep, goats, pigs, dogs and cats.

Vetfen also has ovicidal effect.

DOSAGE
For Roundworms / Tapeworms
To be administered orally @ 5 mg Fenbendazole /kg body weight in all animals (except
in dogs/cats) for roundworms infestation i.e. one bolus of 1.5 g for 300 kg body weight.
or 150 mg for 30 kg body weight in dogs and cats, the basic dosage is 50 mg
Fenbendazole / kg body weight to be given daily in divided doses for 3 days.

Pack
Vetfen-B is available in strip of 2’s.
 BACK
TO

Prazital PRODUCT
RANGE

(Tablet of Pyrental Pamoate + Praziquantel)

Prazital is a formidable combination of Praziquantel and Pyrantel Pamoate and it

offers assured elimination of roundworms, hookworms, ascarides and tapeworms.

COMPOSITION
Each Tablet contains
Praziquantel : 20 mg
Pyrantel Pamoate : 230 mg

INDICATIONS
It is a broad spectrum endoparaciticide used for the treatment and elimination of
roundworms, hookworms, ascarides and tapeworms in feline.

PRAZIQAUNTEL
Novel anthelmentic with excellent activity against all species of tapeworms and
schistosomes. It belongs to the group lsoquinolones.

Well distributed to all organs passes brain barrier.

DOSE
Effective against both adult and juveniles also against cestode larvae or adults at One tablet per 4 kg B.wt.
varied location - Muscle, brain, peritoneal cavity, bile duct, intestines etc-Highly safe.
SPECIAL INSTRUCTIONS
PYRENTAL PAMOATE Keep the drug out of the reach of children. Part used tablets must be discarded. For
Poorly soluble in water-higher efficacy on parasites at lower end of large intestine. Veterinary use only.

Cholinergic agonist-mimics effective of excessive amounts of acetyl choline-causes SHELF LIFE

irreversible paralysis of worms. 36 months from the date of manufacture, when stored at recommended storage
conditions.
Highly effective against common hookworms (Ancylostoma caninum) and Ascarides.
STORAGE
High safety index in dogs : 138 times therapeutic dose. Store in a cool and dark place. The storage temperature should not exceed 25°C.

ADMINISTRATION PRESENTATION
Can be given mixed with food. Strip of 10’s
 BACK
TO

Prazital Plus PRODUCT

RANGE

(Tablet of Fenbendazole + Pyrental Pamoate + Praziquantel)

Prazital is a formidable combination of Fenbendazole, Pyrantel Pamoate and

Praziquantel and it offers assured elimination of roundworms, hookworms, ascarides
and tapeworms.

COMPOSITION
Each Tablet contains : Fenbendazole USP : 150 mg, Pyrantel Pamoate : 144 mg and
Praziquantel : 50 mg

INDICATIONS
It is a broad spectrum endoparaciticide used for the treatment and elimination of
roundworms, hookworms, ascarides and tapeworms in dogs and puppies.

FENBENDAZOLE
Longer availability in body than other benzimidazoles, which ensures complete
elimination of round worms. Non-teratogenic, completely safe even in pregnant animals.
Ovicidal and larvicidal.

PYRENTAL PAMOATE DOSE

Poorly soluble in water-higher efficacy on parasites at lower end of large intestine. One tablet per 10 kg B.wt.
Cholinergic agonist-mimics effective of excessive amounts of acetyl choline-causes
irreversible paralysis of worms. Highly effective against common hookworms SPECIAL INSTRUCTIONS
(Ancylostoma caninum) and Ascarides. High safety index in dogs : 138 times therapeutic Keep the drug out of the reach of children. Part used tablets must be discarded. For
dose. Veterinary use only

PRAZIQAUNTEL SHELF LIFE

Novel anthelmentic with excellent activity against all species of tapeworms and 36 months from the date of manufacture, when stored at recommended storage
schistosomes. It belongs to the group lsoquinolones. Well distributed to all organs conditions.
passes brain barrier. Effective against both adult and juveniles also against cestode
larvae or adults at varied location – Muscle, brain, peritoneal cavity, bile duct, intestines STORAGE
etc-Highly safe. Store in a cool and dark place. The storage temperature should not exceed 25°C.

ADMINISTRATION PRESENTATION
Can be given directly or mixed with food. Strip of 2’s
 BACK
TO

Levaxinide PRODUCT
RANGE

(Levamisole Hydrochloride and Oxyclozanide Suspension)

Levaxinide is a broad spectrum anthelmintic (fluke and worm drench) for the treatment
and control of nematode infections and chronic fasciolasis in cattle, sheep and goats.

INDICATIONS
A broad spectrum anthelmintic (fluke and worm drench) for the treatment and control
of nematode infections and chronic fasciolasis in cattle, sheep and goats. It is also
effective against amphistomes, paramphistomes and tapeworm segments.

COMPOSITION
Each 5 ml contains Levamisole I.P (Vet) 75 mg and Oxyclozanide I.P. (Vet) 150 mg.

ADMINISTRATION
By oral drenching.

DOSAGE
Cattle, Sheep and Goats (for roundworms) : 0.33 ml/kg body weight.

General dosage
Cattle : 33 ml / 100 kg body weight up to a maximum of 100 ml.
Sheep and Goats : 5 ml up to 15 kg body weight and 10 ml up to 30 kg body weight.

WITHDRAWAL PERIOD
Meat : 14 days
Milk : 24 hours

SHELF LIFE SPECIAL INSTRUCTIONS

24 months from the date of manufacture. Keep the drug out of the reach of children. Shake well before use.

STORAGE PACKING
Store in a cool and dark place (below 250C) Levaxinide is available in 1 lit. packs.
 BACK
TO

Rafonide PRODUCT
RANGE

(Rafoxanide Suspension I.P (Vet) 3%)

Rafonide (Rafoxanide 3% suspension) is an Anthelmintic and is used for the treatment

and control of Liverflukes and other worms.

DESCRIPTION
Rafonide is an anthelmintic liquid suspension used for the treatment and control of
mature and immature Fasciola flukes , Haemonchus, Bonostomus round worms, Nasal
bots and Fly maggots.

COMPOSITION
Each 5 ml contains Rafoxanide I.P. (Vet) : 150 mg

INDICATIONS
Rafonide is used for the treatment and control of Liver flukes and other worms.

ADMINISTRATION
By oral drenching
SPECIAL INSTRUCTIONS
DOSAGE Keep the drug out of the reach of children. Shake well before use.
Calf, Cattle, Buffaloes, Sheep, Goats : 1 ml for 4 kg B.Wt
WITHDRAWAL PERIOD
SHELF LIFE Meat : 28 days
24 months from the date of manufacture. Milk : 10 days (for cows) & 7 days (for Goats)

STORAGE PRESENTATION
Store in a cool and dark place (below 250C) Rafonide is available in 1 liter pack
 BACK
TO

Trichloben PRODUCT
RANGE

(Triclabendazole 5% w/v Suspension)

Trichloben is used for the treatment and control of mature and immature liver flukes
Fasciola hepatica and Fasciola gigantica in sheep and goats.

COMPOSITION
Each 5 ml contains Triclabendazole 250 mg.

INDICATIONS
Trichloben is used for the treatment and control of mature and immature liver flukes
Fasciola hepatica and Fasciola gigantica in sheep and goats.

DOSAGE
Sheep and Goats : 1 ml per 5 kg B.Wt.

ADMINISTRATION
By oral drenching

SPECIAL INSTRUCTIONS
Keep the drug out of the reach of children. Shake well before use.

WITHDRAWAL PERIOD
Meat : 28 days and Milk : 10 days (in case of cows) & 7 days (in case of Goats)

STORAGE
Store in a cool and dark place (below 250C)

PACKING
Trichloben is available in 1.0 lit. packs
 BACK
TO

Prozal PRODUCT
RANGE

(Diminazene Aceturate Granules)

DESCRIPTION
Prozal is a Chemotherapeutic Agent used for the treatment and control of
Typanosomiasis, Babesiosis and Theileriosis in animals.

COMPOSITION
Each 2.36 gram contains 1.05 gram of Diminazene aceturate.

INDICATIONS
Prozal is a very effective and well tolerated drug used for the treatment and control of
Typanosomiasis, Babesiosis and Theileriosis in animals.

Trypanosomiasis : Caused by Trypanosoma congolense, T.vivax, T.brucei

Babesiosis ( Piroplasmes ) : Caused by Babesia bovis, B. bigemina, B. ovis, B.
motasi,
B.canis and Theileria annulata.
Prozal is also suitable for the treatment of mixed infections with trypanosomes and The Prozal granules dissolve rapidly in the volume of indicated for injection. The
piroplasmes also pyrexia of unknown origin. prepared Injection solution is stable for 5 days and when stored at a cool place for 14
days. The injection solution must be protected from sunlight and must be stored in
CONTRA INDICATIONS sealed glass vials.
Do not use for camels and dogs.
Prozal can be administered either by deep intramuscular route or by subcutaneous
DOSAGE & ADMINISTRATION route.
The dose for all animals when infected with Babesiosis, T.congolense, T.vivax is
0.8 g of Prozal granules per 100 kg b.w. For infections with T.brucei, twice this quantity STORAGE
is indicated. Store in a cool and dry place.

5 ml of injection solution per 100 kg b.w. PRESENTATION

Preparation of injection solution : Dissolve 2.36 g of Prozal in 12.5 ml water Prozal is available in 2.36 g glass bottles and 2.36 g sachets. 100 sachets are packed
(amounts 15 ml) in a corrugated box.
 BACK
TO

Trepanol PRODUCT
RANGE

(Quinapyramine Sulphate & Quinapyramine Chloride Injection)

DESCRIPTION
Trepanol is used for the treatment and control of Typanosomiasis in cattle, camels,
horses and dogs.
DOSAGE & ADMINISTRATION
COMPOSITION Preparation of injection solution
Each 2.5 g of Trepanol contains : Dissolve 2.5 g of Trepanol in 15 ml sterile water.
Quinapyramine Sulphate : 1.5 g
Quinapyramine Chloride : 1.0 g For the treatment of T. congolense
1 ml of injection solution per 45 kg b.w.
INDICATIONS
Trepanol is a very effective and well tolerated drug used for the treatment and control For T. evansi, T. equiperdum, T. equinum
of Trypanosomiasis in cattle, camels, horses and dogs. 1.3 ml of injection solution per 45 kg b.w.

Trypanosomiasis For T. vivax, T. brucei (mixed infection with T. congolense), T. simiae

Caused by Trypanosoma congolense, T. vivax, T. brucei, T. evansi,
T.equiperdurm, T.equinum, T.simiae.
Trepanol is also suitable for the treatment of mixed infections of trypanosomes.
Generally Trepanol provides 2 - 3 months prophylaxis.
PRECAUTIONS
Trepanol is safe and free from side effects. However stressed animals should be
rested before treatment. If mild salivation, restlessness or tremors are observed the
animal should be kept quiet until symptoms subside.
2 ml of injection solution per 45 kg b.w.
Trepanol can be administered by subcutaneous route. Behind the shoulder and midline
of the dewlap or caudal fold are the common sites for injection in cattle. In horses in
front of the shoulder is the usual site for injection.
STORAGE
Store in a cool and dry place.
PRESENTATION
Trepanol is available in 2.5 g glass bottles along with diluent.
 BACK
TO

Tikkil (Powder) PRODUCT

RANGE

(Cypermethrin WDP 10 % w/w)

DESCRIPTION
Tikkil is a highly effective ecto parasiticide containing synthetic pyrethroid Cypermethrin smoke during treatment. Wash hands thoroughly after use before eating, drinking
high Cis 10% w/w. and smoking. In case of indisposition, seek medical aid. If swallowed refer to a doctor
or nearest hospital. Apply symptomatic therapy. Do not treat ill, weak, exhausted or
COMPOSITION thirsty animals. Keep the product out of reach of children, pets and foodstuff. Tikkil
Each gm contains Cypermethrin high Cis 10% w/w should not be sprayed on feed and feed bags. Keep away from heat open flame.
Destroy empty sachets / pouches.
INDICATIONS
Tikkil is a broad spectrum ectoparasiticide used for the control of flies of cattle and ANTIDOTE
horses, blowfly larve, biting lice, ticks and headflies of sheep and mites of poultry, In case of ingestion, carry out gastric lavage with care to prevent aspiration. Treat
scabies and mange mites of cattle, sheep and dog ticks and lice. symptomatically.

MODE OF ACTION WITHDRAWAL PERIOD

Tikkil exerts its action on sodium channels of parasite nerve axons causing initial No withdrawal period for milk. 3 days pre-slaughter interval for meat.
excitement and then paralysis.
DOSAGE & ADMINISTRATION
INDICATIONS Tikkil is to be mixed with water and sprayed on the animal.
Flies on cattle and horses, blowfly larve, biting lice, ticks and head flies on sheep and
remites on poultry, scab and mange mites on cattle, sheep and dogs. DOSAGE AND ADMINISTRATION
Dilution rate / Lit. Water Use for
CONTRA INDICATIONS
Treatment of lambs less than one week of age or treatment of animals during hot Cattle, Camel 1 gm Whole body spray dip, initial charge &
weather should be avoided. Not to be applied on the tail region of the lambs because replenishment
this could interfere with ewe-lamb recognition. Cattle 5 gm Back line spray 0.5 lit / animal.

WARNING Sheep and Goats 1 gm Dip, initial charge & replenishment.

Wash udders of sprayed animals before milking and apply only to unbroken lesions. Dogs 1 gm Whole body spray or wash
Accidental splashes on skin must be washed immediately with soap and plenty of
Poultry 1 gm 60 lit of spray mixture per 1000 birds
water.
Animal Hosing 20 gm 5 liters of emulsion per 100 sq.m. surface
PREACUTIONS
Avoid contact with concentrate and emulsion. Accidental splashes on skin and clothes STORAGE Store in a cool and dry place.
must be washed with soap and plenty of water. Avoid contact with skin, eyes or swal-
lowing. Avoid breathing spray mist. Wear protective clothing. Do not eat, drink and PRESENTATION Tikkil is available in 5 gm and 15 gm sachets / pouches.
 BACK
TO

Tikkil (Solution) PRODUCT

RANGE

( Cypermethrin High Cis Emulsifiable Concentrate (Vet.))

Tikkil is a highly effective ecto parasiticide containing synthetic pyrethroid Cypermethrin smoke during treatment. Wash hands thoroughly after use before eating, drinking and
high Cis 10% w/v. smoking. In case of indisposition, seek medical aid. If swallowed refer to a doctor or
nearest hospital. Apply symptomatic therapy. Do not treat ill, weak, exhausted or thirsty
COMPOSITION animals. Keep the product out of reach of children, pets and foodstuff. Tikkil should
Each ml contains Cypermethrin high Cis 10% w/v (100 g per liter). not be sprayed on feed and feed bags. Keep away from heat open flame. Destroy
empty containers.
INDICATIONS
Tikkil is a broad spectrum ectoparasiticide used for the control of ticks, lice, scab and ANTIDOTE
mange mites, and flies on Cattle, Sheep, Goat, Horse, Camel, Poultry, Dogs and In case of ingestion, carry out gastric lavage with care to prevent aspiration. Treat
Farm Premises. symptomatically.

MODE OF ACTION WITHDRAWAL PERIOD

Tikkil exerts its action on sodium channels of parasite nerve axons causing initial No withdrawal period for milk. 3 days preslaughter interval for meat.
exitement and then pralysis.
DOSAGE & ADMINISTRATION
INDICATIONS Tikkil can be used either as a spray or dip treatment.
Flies on cattle and horses, blowfly larve, biting lice, ticks and headflies on sheep and
remites on poultry, scab and mange mites on cattle, sheep and dogs. Dosage And Administration
Species Dilution rate with Water Application
CONTRA INDICATIONS
Treatment of lambs less than one week of age or treatment of animals during hot Cattle 1 ml / lit water (for ticks) Whole body spray dip, initial charge &
weather should be avoided. Not to be applied on the tail region of the lambs because Camel replenishment
this could interfere with ewe-lamb recognition. Cattle 5 ml / lit water (for flies) Back line spray 0.5 lit / animal.
Sheep 1 ml / lit water (for scab & lice) Dip, initial charge & replenishment.
WARNING Dogs 1 ml / lit water (for ticks, lice, mites, flies) Whole body spray or wash
Wash udders of sprayed animals before milking and apply only to unbroken lesions. Poultry 1 ml / lit water (for ticks, lice, mites, flies) 60 lit of spray mixture per 1000 birds
Accidental splashes on skin must be washed immediately with soap and plenty of
Animal 20 ml / lit water 5 liters of emulsion per 100 sqm surface
water.
Housing
PREACUTIONS
STORAGE Store in a cool and dry place.
Avoid contact with concentrate and emulsion. Accidental splashes on skin and clothes
must be washed with soap and plenty of water. Avoid contact with skin, eyes or swal-
PRESENTATION
lowing. Avoid breathing spray mist. Wear protective clothing. Do not eat, drink and
Tikkil is available in 15 ml and 50 ml Aluminium bottles.
 BACK
TO

Oxytetracycline PRODUCT
RANGE

(Oxytetracycline Dyhidrate) I.P 50 mg

DESCRIPTION
Oxytetracycline Injection is a golden yellow aqueous solution.

COMPOSITION
Each ml contains Oxytetracycline Dyhydrate I.P. 50 mg.

INDICATIONS
For the treatment of systemic, respiratory, gastro intestinal and urinary infections caused
by oxytetracycline sensitive organisms. Haemoprotozoal diseases like Thieleriosis,
Trypanosomiasis, Babesiosis and Anaplasmosis.

ADMINISTRATION
Oxytetracycline injection may be given by intravenous, intramuscular or subcutaneous
routes.

DOSAGE CAUTION
Cattle, Buffaloes & Horses : 10-20 mg/kg b.wt. depending on severity Generally well tolerated. However, weak and debilitated animals do not tolerate it
of infection. well.
Calves, Sheep, Goats, Pigs and Dogs : 0.5 ml to 1.0 ml
(per 5 Kg body wt. for 3-5 days). Milk form lactating cows, buffaloes undergoing treatment as well as up to 48 hours
after completion of treatment, should not be used for human consumption.
FOR POULTRY
For chicks upto 4 weeks of age, use diluted solution by adding 3 parts of sterile water WITHDRAWAL PERIOD
to one part of Oxytetracycline injection. Meat : 14 days
Chicks upto 2 weeks of age : ½ ml diluted injection Milk : 3 days
Chicks 2-4 weeks of age : 1 ml diluted injection
Chicks 4-8 weeks of age : ½ ml undiluted injection PACKING
Chicks over weeks of age : 1 ml of undiluted injection 30 ml, 50 ml and 100 ml vials.
 BACK
TO

Tetroxin-DS PRODUCT
RANGE

(Oxytetracycline Injection 100mg/m)

DESCRIPTION
Tetroxin - DS is a clear and stable solution of Oxytetracycline dihydrate.

COMPOSITION
Each ml contains :
Oxytetracycline dihydrate I.P. 100 mg

INDICATIONS
For the treatment of systemic, respiratory, gastro intestinal and urinary infections caused
by Oxytetracycline sensitive organisms.

DOSAGE AND ADMINISTRATION PRECAUTIONS

Cattle, Horses, Foals, Calves, Pigs & Sheep : 5 – 10 mg / kg / day Intravenous injections must be given slowly. In cold weather Tetroxin-DS should be
1 - 2 ml /20 kg – intramuscular (IM), Slow intravenous (IV) warmed to about 20°C before injection.

Dogs & Cats : 10 mg / kg / day Do not administer to horses under stress, as fatal diarrhea may occasionally arises.
0.5 ml / 5 kg - IM Store in a cool place. Protect from light.

Treatment should be repeated 2 – 4 days at 24 hours intervals. If there is no response WITHDRAWAL PERIOD
to treatment, the diagnosis and therapy should be reviewed after 48 hours. Meat : 15 days Milk : 3 days

Treatment of anaplasmosis in cattle requires ten treatments with a dosage of 10 ml PRESENTATION

per 100 kg body weight. Tetroxin - DS is available in 30 ml & 100 ml packs.
 BACK
TO

Tetroxin-LA PRODUCT
RANGE

(Oxytetracycline Injection 20 % Long Acting )

DESCRIPTION
Tetroxin-LA 20% is a clear and stable solution of Oxytetracycline dihydrate.

COMPOSITION
Each ml contains :
Oxytetracycline dihydrate I.P. 200 mg equivalent to anhydrous Oxytetracycline in 2-
Pyrrolidone vehicle system.

INDICATIONS
For the treatment of systemic, respiratory, gastro intestinal and urinary infections caused
by Oxytetracycline sensitive organisms.
PRECAUTIONS
ADMINISTRATION Generally well tolerated. However, weak and debilitated animals do not tolerate well.
Tetroxin - LA injection may be given by intramuscular injection in divided doses to be
administered at 2 to 3 sites. Milk from lactating cows, buffaloes undergoing treatment as well as upto 48 hours
after completion of treatment, should not be used for human consumption.
By subcutaneous route in poultry and rabbits.
WITHDRAWAL PERIOD
DOSAGE Meat : 22 days
Cattle, Buffaloes, Sheep, Goats, Pigs & Camels : Single dose at the rate of 1 ml per Milk : 3 days
10 Kg. Body wt.
PRESENTATION
Poultry and Rabbits : 1 ml per 4 Kg body wt. Tetroxin - L.A. is available in 100 ml packs.
 BACK
TO

Gyroflox PRODUCT
RANGE

(Enrofloxacin10% Injection)

COMPOSITION
Each ml of injection contains Enrofloxacin 100 mg.
ADMINISTRATION
INDICATIONS Gyroflox injection should be administered by subcutaneous / Intravenous route only.
Gyroflox being a broad spectrum antibacterial is indicated in either single or mixed Tablet by oral route : 1 tablet/10 kg Body wt.
bacterial infections.
DOSAGE
In Livestock Ruminants : 1 ml/40 kg Body wt.
Gyroflox is effective against E.coli, Salmonella Spp., Pasteurella Spp., Klebsiella Spp., Dog, Cat : 1 ml/20 kg Body wt.
Moraxella bovis, Campylobacter Spp., Haemophilus Spp., Pseudomonas aeruginosa, Poultry : 1 ml/10 kg. Body wt.
Brucella canis. Stephylococcus Spp., Streptococcus Spp., Corynebacterium pyogenes,
Clostridium perfringens, Erysipelothrix, Mycoplasma Spp., and others like Leptospira PACK
Spp. Hence Gyroflox is suitable for the treatment of infections such as : Coli-diarrhoea, Gyroflox injection is available in 2 ml, 15 ml & 50 ml vials.
Coli Septicaemia, Bronchopneumonia, Enzootic pneumonia, Salmonellosis, Acute
Mastitis, Enteritis, Colibacillosis, Clostridiosis, MMA Complex, Urinary tract infection, SHELF LIFE
Wound infection and Secondary bacterial infection associated with viral diseases. 24 months from the date of manufacture when stored at the recommended storage
conditions.
In Poultry
Gyroflox is effective in infections with Gram - negative and Gram – positive bacteria WITHDRAWAL PERIOD
and Mycoplasma. Meat : 14 days, Milk : Not applicable

BENEFITS CAUTION AND CONTRAINDICATIONS

Effective against all major bacterial infections of gastrointestinal, respiratory and
urogenital systems.
A true broad spectrum antibacterial that controls gram-negative and gram-positive
bacteria and mycoplasma infections.
Acts rapidly against proliferating and dormant phase of pathogens.
Maximum effective concentration in blood serum is achieved within 1-2 hours.
Able to penetrate placenta and blood brain barrier.
Safe and free from side effects. Contains safe preservative-Methyl & Propyl Paraben.
Gyroflox should not be administered to dogs below 12 months of age and is not to be
used to treat horses. Gyroflox is not recommended in combination with chloramphenicol,
Macrolides, Tetracyclines, Megnesium and Aluminium containing substances might
hamper the absorption of Gyroflox from the gastro-intestinal tract.
WARNING
Keep the drug out of reach of children. Shake will before use. Protect from light and
freezing. Store in cool and dark place below 25°C. For veterinary use only.
 BACK

Gyroflox (Tablets) TO
PRODUCT
RANGE

(Enrofloxacin Tablets 50 mg)

COMPOSITION
Each tablet contains Enrofloxacin 50 mg. BENEFITS
Effective against all major bacterial infections of gastrointestinal, respiratory and
INDICATIONS urogenital systems.
Gyroflox being a broad spectrum antibacterial is indicated in either single or mixed
bacterial infections. A true broad spectrum antibacterial that controls gram-negative and gram-positive
bacteria and mycoplasma infections.
In Livestock
Gyroflox is effective against E.coli, Salmonella Spp., Pasteurella Spp., Klebsiella Spp., Acts rapidly against proliferating and dormant phase of pathogens.
Moraxella bovis, Campylobacter Spp., Haemophilus Spp., Pseudomonas aeruginosa,
Brucella canis. Stephylococcus Spp., Streptococcus Spp., Corynebacterium pyogenes, Maximum effective concentration in blood serum is achieved within 1-2 hours.
Clostridium perfringens, Erysipelothrix, Mycoplasma Spp., and others like Leptospira
Spp. Hence Gyroflox is suitable for the treatment of infections such as : Coli-diarrhoea, Able to penetrate placenta and blood brain barrier.
Coli Septicaemia, Bronchopneumonia, Enzootic pneumonia, Salmonellosis, Acute
Mastitis, Enteritis, Colibacillosis, Clostridiosis, MMA Complex, Urinary tract infection, Safe and free from side effects.
Wound infection and Secondary bacterial infection associated with viral diseases.
ADMINISTRATION
In Poultry Tablet by oral route
Gyroflox is effective in infections with Gram - negative and Gram - positive bacteria
and Mycoplasma. DOSAGE
1 tablet/10 kg Body wt.
In Dogs & Cats
For the treatment of diseases associated with bacteria susceptible to PACK
enrofloxacin. Strip of 10’s
 BACK
TO

Gyroflox PRODUCT
RANGE

(Enrofloxacin 10% Oral Suspension)

COMPOSITION achieved within 1-2 hours. Able to penetrate placenta and blood brain barrier. Safe
Each ml of Gyroflox Suspension contains Enrofloxacin 100 mg. and free from side effects.

INDICATIONS ADMINISTRATION
Gyroflox being a broad spectrum antibacterial is indicated in either single or mixed Oral through the drinking water
bacterial infections.
DOSAGE
In Livestock General Dosage for Poultry : 0.1 ml of Gyroflox oral per kg. body weight. . It is obtained
Gyroflox is effective against E.coli, Salmonella Spp., Pasteurella Spp., Klebsiella Spp., by administering 0.5 litres (50 g of enrofloxacin) per 1000 litres of drinking water for
Moraxella bovis, Campylobacter Spp., Haemophilus Spp., Pseudomonas aeruginosa, three consecutive days.
Brucella canis. Stephylococcus Spp., Streptococcus Spp., Corynebacterium pyogenes, In the case of salmonellosis, the length of treatment is 5 days.: Renew medicated
Clostridium perfringens, Erysipelothrix, Mycoplasma Spp., and others like Leptospira water after 24 hours.
Spp. Hence Gyroflox is suitable for the treatment of infections such as : Coli-diarrhoea,
Coli Septicaemia, Bronchopneumonia, Enzootic pneumonia, Salmonellosis, Acute The general dosage for all Ruminants : 0.25 ml / 10 Kg B.Wt. for 3 - 5 days
Mastitis, Enteritis, Colibacillosis, Clostridiosis, MMA Complex, Urinary tract infection,
Wound infection and Secondary bacterial infection associated with viral diseases. Dogs & Cats : 0.5 ml per 10 kg. B. Wt.

In Poultry WITHDRAWAL PERIOD

Gyroflox is effective in infections with Gram - negative and Gram - positive bacteria
and Mycoplasma.
Gyroflox is used for the treatment of colibacillosis, salmonellosis and infections caused
by mycoplasma. Before administration, check the sensitivity of the causing agent to
enrofloxacin with an antibiogram. Provided that an increase of resistances can appear
during treatment, the speciality should only be administered after ensuring the
bacteriological diagnostic and when resistance to other antibiotics exists
In Dogs & Cats
For the treatment of diseases associated with bacteria susceptible to enrofloxacin.
Meat : 14 days, Milk : 3 days.
CAUTION
Do not exceed the recommended dosage. Do not administer in case of resistance to
the quinolones, because of cross-resistance. In relation to fluoroquinolones, a complete
cross-resistance exists. Do not treat animals with previous case of streptococcal
infections.
Like fluoroquinolones, enrofloxacin has a damaging action on articulations, especially
in young animals. Consequently, caution must be taken in not increasing excessively
the dose and length of treatment.

Benefits : Effective against all major bacterial infections of gastrointestinal, respiratory Antagonic effects can appear administering it together with chloramphenicol,
and urogenital systems. A true broad spectrum antibacterial that controls gram-negative maccolides, or tetracyclines.
and gram-positive bacteria and mycoplasma infections. Acts rapidly against proliferating
and dormant phase of pathogens. Maximum effective concentration in blood serum is PACK Gyroflox is available in 1.0 lit. packs.
 BACK
TO

Inimox PRODUCT
RANGE

(Amoxycillin + Cloxacillin Injection)

DESCRIPTION
Inimox is a Crystalline Injectable Powder presented in glass vials

COMPOSITION
Each 2000 mg Vial contains :

Amoxycillin Sodium B.P. equivalent to Anhydrous Amoxycillin 1g

Cloxacilin Sodium I.P. equivalent to Cloxacilin 1g

INDICATIONS
Inimox is a tried combination therapy for though infection like

Mastitis, Metritis
Calf Scours, HS, BQ, E-Coli Infections
Brucellosis
Pneumonia, Respiratory tract infections
Pyelonephritis, Salmonellosis

ADMINISTRATION
By intramuscular or intravenous route

DOSAGE
5 - 10 mg per kg body wt. by intramuscular or intravenous route after dissolving the
contents of the vials with sterile water for injection for 3 - 5 days or as directed by the
veterinarian.

WITHDRAWAL PERIOD
Meat : 2 weeks
Milk : 3 days

PACKING
2000 mg and 4000 mg. in glass vials.
 BACK
TO

G-Cin PRODUCT
RANGE

(Gentamicin 10% Water Soluble Powder)

G-Cin WSP (Gentamicin 10% Water Soluble Powder) is used for treatment and control
of Gastrointestinal infections in poultry, calves and swine. Other gastrointestinal DOSAGE
infections caused by Gentamicin – susceptible microorganisms. It is also used for the Calves : 5 g of powder per 100 kg. b.wt. twice on the first day only, and 4 g of powder
treatment of swine dysentery. once in a day thereafter for 3 – 5 days.

COMPOSITION
Each gram Gentamicin Sulphate is equivalent to Gentamicin 100 mg.
INDICATIONS
In Cattle : G-Cin WSP is used for the treatment and control of Gastrointestinal
infections, caused by gentamicin susceptible microorganisms.
Poultry : 0.5 gm of powder in 1.0 liter of drinking water for 5 to 7 days.
Swine : 5 g of powder per 100 kg b.wt. or 5g of powder per 10 liters of drinking water
at 12 hours intervals for 3 – 5 days. For the treatment of swine dysentery : 11 – 22 g of
powder in 100 liters of drinking water for 3 – 5 days.
SIDE EFFECTS : Nil

In Poultry : For prevention of early chick mortality due to E.coli, Salmonella spp. & WARNING
Pseudomonas spp., Fowltyphoid, C.R.D, infectious coryza and paratyphoid infections. Do not use Gentamicin powder concurrently with Chloramphenical.
For reduction and elimination of micro-organisms like Mycoplasma & Salmonella from
hatching eggs by dipping them in Gentamicin medicated water before incubation. WITHDRAWAL PERIOD
Other gastrointestinal infections caused by gentamicin susceptible microorganisms. Meat : 10 days

ADMINISTRATION STORAGE
Orally by drinking water Store in a cool and dark place (below 250C)

CONTRAINDICATIONS PRESENTATION
Hypersensitivity to gentamicin G-Cin WSP is available in 500 g packs.
 BACK
TO

Sulfamin PRODUCT
RANGE

Injection B.P (Vet)

DESCRIPTION
A clear aqueous injectable solution containing Sulphadimidine Sodium.

COMPOSITION
Each ml contains :

Sulphadimidine Sodium I.P. 333 mg.

INDICATIONS
Sulfamin is recommended for the treatment of systemic, enteric infections in domestic
animals due to sulphonamide sensitive organisms. It is indicated in the treatment of
Haemorrhagic septicaemia, bronchopneumonia, calf diphtheria, bacterial enteritis and
actinobacillosis. It is also indicate as a supportive therapy in metritis and mastitis of
adult cattle and in coccidiosis of calves.

ADMINISTRATION
Sulfamin injection may be given by intravenous or subcutaneous routes.

DOSAGE
30 ml per 50 Kg. Body weight initial dose.
15 ml per 50 Kg. Body weight on subsequent days over a period of 4 to 6 days.

PRECAUTIONS
Generally well tolerated. However, weak and debilitated animals do not tolerate well.

PRESENTATION
Sulfamin injection is available in 100 ml and 450 ml packs.
 BACK
TO

Vetylosin PRODUCT
RANGE

(Tylosin Water Soluble Powder)

114 - 118 gm. Water soluble powder

COMPOSITION
Each Vetylosin pack contains active Tylosin base : 100 gm.

DOSAGE
Poultry
0.50 gm. of Vetylosin per liter of drinking water (for 2 to 5 days)

Calves
1.0 gm. of Vetylosin dissolved in water / milk per lactating calf
(daily 2 times for 5 to 7 days).

ADMINISTRATION
Orally by drinking water.

INDICATIONS
Poultry : For the treatment and control of CRD and infectious synusitis.
Lactating Calves : For the treatment and control of pneumonia associated with
pasteurellas and mycoplasmas. STORAGE
Store in a cool and dark place (below 250C)
WITHDRAWAL PERIOD
Poultry : 24 hours SPECIAL INSTRUCTIONS
Meat (Calves) : 21 days Keep the drug out of the reach of children. Shake well before use.

SHELF LIFE PACKING

24 months from the date of manufacture. Vetylosin is available in 114 -118 g packs.
 BACK
TO

Lithiomony PRODUCT
RANGE

Lithium Antimony Thiomalate Injection

DESCRIPTION
Lithium Antimony Thiomalate is an organic compound offered as aqueous solution..

COMPOSITION
Each ml contains :

Lithium Antimony Thiomalate : 6% w/v

Equivalent to 12 mg Antimony Trioxide :
Chlorocresol (preservative) IP : 0.1% w/v

INDICATIONS
Lithium Antimony Thiomalate should be administered by deep intramuscular route
preferably at the gluteal muscles.

DOSAGE
For Nasal Granuloma
15 ml to 20 ml on three occasions at weekly intervals.

Papillomatosis
15 ml to 20 ml on 4-6 occasions on alternative days.
As warts necrose, they should be enucleated and suitably dressed.

Filariasis and Leishmaniasis in canines

1 ml to 2.5 ml on 4-6 occasions on alternative days.
The dosage may be gradually increased.

PRESENTATION
Lithiomony injection is available in 50 ml glass vials.
 BACK
TO

Inigesic PRODUCT
RANGE

(Analgesic, antipyretic & anti-inflammatory injection & bolus)

COMPOSITION
Each ml of injection contains Paracetamol IP 150 mg., Diclofenac Sodium IP 25mg.,
Benzyl alcohol IP 1% w/v.

Each uncoated bolus contains Diclofenac Sodium IP 250mg., Paracetamol IP 1500

mg.

INDICATIONS
For the treatment of pain and fever associated with injury and surgery, chronic inflam-
matory conditions, fever caused by inflammation, smooth muscle swelling in per acute
and acute mastitis. Also in other inflammatory conditions viz.rheumatoid arthritis,
ostearthritis, tenosynovitis, mystis, neuritis, fibrositis, coxitis, gonitis, swelling in trau-
matic and surgical wounds and also in ephemeral fever, neuralgia and lumbago.

ADMINISTRATION
Inigesic injection should be administered by deep intramuscular route.

DOSAGE
Injection : 1 ml per 25 kg body wt.

Bolus
Large animals : 1-2 boli twice daily.
Small animals : 1/2 – 1 bolus twice daily.

Do not use in cat and Horse

PACK
Inigesic injection is available in 30 ml vials.
Inigesic bolus is available in strip of 2 Boli.
 BACK
TO

Nimovet PRODUCT
RANGE

Nimesulide Injection 10% w/v

ROUTE OF ADMINISTRATION
COMPOSITION Intra-muscular.
Each ml contains: Nimesulide 100 mg
DOSAGE INTERVAL
DESCRIPTION At 24 hourly intervals.
Nimesulide is a non-steroidal anti-inflammatory drug (NSAID) that has antipyretic
and analgesic properties. The anti-inflammatory, analgesic and antipyretic activities INDICATIONS FOR USE
of Nimesulide, a drug belonging to the same class of Sulfonanilide, have been Pyrexia, Musculoskeletal affections (Limping, Lameness, joint affections, sprain,
demonstrated in a number of experimental models and in numerous clinical trials. The trauma, wounds, arthritis, Bursitis, Sinuvitis etc)
compound is weakly acidic (pKa = 6.5) and differs from other NSAIDs as it contains in ENT affections (Rhinitis, Pharyngytis, Otitis etc)
its chemical structure the acid group of the Sulfonanilide molecule. Nimesulide has Other Systemic or infectious diseases (Upper or lower respiratory tract infections,
exhibited a pharmaceutical power similar to other agents, such as Indomethacin, FMD, Contagious ecthyma, mastitis etc)
Diclofenac, Piroxicam and Ibuprofen in standard animal models of inflammation. The Post operative or surgical inflammatory conditions.
analgesic potency of Nimesulide is similar to that of ibuprofen and indomethacin.
Nonetheless Nimesulide has shown a higher antipyretic potency than indomethacin, CONTRA-INDICATIONS
ibuprofen, aspirin and Paracetamol. Acute renal failures, Marked hepatic dysfunctions, blood dyscrasias, pregnancy,
The mechanism by which Nimesulide exerts its action is complex. Nimesulide appears ulcerative gastro intestinal diseases, cardiac diseases and in neonates.
to act at different stages of the inflammatory reaction and selectively, it is a COX-2
inhibitor. Nimesulide has the unique feature of exhibiting multifaceted actions. NOT TO BE USED IN HORSES.
Nimesulide inhibits Prostaglandin synthesis at the sites of inflammation. It acts as a
competitive inhibitor of histamine and in-vitro reduces the super oxide anion formation SPECIAL PRECAUTIONS
by activated neutrophils. Nimesulide and its active metabolite also appear to have Warfarin poisoning, Haemolytic diseases, renal and hepatic dysfunctions, severe
direct anti-oxidant properties against various free radicals. It also inhibits the platelet cardiac diseases and in pregnancy.
activating factor and integrin. Nimesulide may prevent the cartilage damage by inhibiting
metalloprotienase and cytokines. POSSIBLE SIDE EFFECTS
DOSAGE RECOMMENDATION: In dogs and cats, Nimesulide may be painful, especially in large doses, in a few cases,
it may cause mild gastritis in dogs. Abortion may occur if administered to pregnant
DOGS AND CATS animals.
3-5 mg per Kg B.wt. In very high doses, Nimesulide may cause gastric irritation and toxicity symptoms in
liver and Kidney.
CATTLE, BUFFALOES, SHEEP AND GOATS Rarely, it causes acute renal failure in new borne and young calves, in puppies and
2-4 mg. per Kg B.wt. Kitten.
 BACK
TO

Pesurea Bolus PRODUCT

RANGE

(INTRAUTERINE BOLUS WITH NITROFURAZONE,

UREA & METRONIDAZOLE)

DESCRIPTION
Pesurea is highly hygroscopical water soluble bolus ideal for intrauterine use. Pesurea
Bolus is an ideal combination of a broad specturum antibacterial (Furazolidone), a
proteolytic agent that acts effectively in the presence of necrotic debris and uterine
fluids (Urea) and a proven antibiotic effective in anaerobic conditions (Metronidazole)

COMPOSITION
Each bolus contains:
Nitrofurazone BP : 60 mg
Urea : 5000 mg
Metronidazole IP : 1000 mg

Why Metronidazole ?
Metronidazole is an antibacterial & antiprotozoal especially effective against anaerobic
infections.
It is an effective antibiotic against certain protozoal infections, especially Giardia.

MODE OF ACTION
The normal body tissues of the body depend on oxygen for survival. However,
abscessed tissues and tumors with poor central circulation do not receive blood supply
and oxygen.

Only anaerobic bacterial can survive these conditions.

In anaerobic conditions, the Metronidazole molecule changes so as to inhibit the DNA
repair enzymes that would normally repair the cells. This means death for anaerobic
bacteria but no effect on aerobic tissues.

Metronidazole is also able to modify cell mediated immunity so as to normalize ADMINISTRATION AND DOSAGE
excessive immune reactions, especially in the large intestine. Using aseptic precautions, insert by hand two to four boluses into each of the affected
and normal uterine horns. Based on severity, repeat treatment after 24 hours.
INDICATIONS
For prevention or control of uterine infections associated with retained placenta, metritis, PRESENTATION
cervicitis and vaginitis Strip of four boli.
 BACK
TO

Calgonate PRODUCT
RANGE

Injection B.P (Vet)

DESCRIPTION
Calgonate is a mixture of calcium gluconate and boric acid.

COMPOSITION
Calcium Gluconate I.P. : 20.80% w/v
(Equivalent to Calcium 1.86% w/v)
Boric Acid I.P. : 4.25 %
Chlorocresol I.P. (as Preservative) : 0.1 %
Water for injection I.P. : q.s.

INDICATIONS
Calgonate is recommended for the treatment of acute and chronic hypocalcaemia in
cows, buffaloes, ewes, doe and sows. It is extensively used in clinical and subclinical
cases of milk fever in cows, buffaloes and other species of domestic animals. It is also
recommended for the prevention and treatment of drug induced liver damage.

ADMINISTRATION
Calgonate may be administered by subcutaneous or intravenous injection. When ad-
ministered intravenously it is of utmost importance to inject the solution slowly as it
has been reported that calcium ions, in some individual animals may have a depres-
sant effect on the myocardium. It is also desirable to warm the Calgonate solution to
body temperature before administration.

DOSAGE
Cows, Buffaloes : 200 ml to 300 ml
Ewes, Doe and Sows : 30 ml to 50 ml

PRESENTATION
Calgonate Injection is available in 450 ml pack.
 BACK
TO

Miphocal PRODUCT
RANGE

(Calcium Borogluconate injection with Magnesium and Phosphorous)

DESCRIPTION
Calcium Borogluconate with Magnesium and Phosphorous is a solution of calcium
borogluconate with phosphorous and magnesium in an organic combination and dex-
trose.

COMPOSITION
Calcium Gluconate I.P.(Equivalent to Calcium 1.86% w/v) : 20.80% w/v
Boric Acid I.P. : 4.25% w/v
Magnesium Hypophosphite : 5.0 % w/v
Anhydrous Dextrose I.P. : 20.0 % w/v
Chlorocresol I.P. (as preservative) : 0.1 % w/v
Water for Injection I.P. : q.s.

INDICATIONS
Miphocal is recommended for the treatment of milk fever due to hypocalcaemia or
when it is associated with hypomagnesaemia and hypophosphataemia.

ADMININSTRATION
Miphocal may be administered by subcutaneous route. Being a hypertonic solution,
may occasionally produce temporary local tissue swelling.

It is suggested that before intravenous administration the solution should be warmed

to body temperature.

Calcium and Magnesium ions if injected rapidly may cause coronary depression and
hence it is advisable to administer this preparation slowly and also with a few interrup-
tions.

DOSAGE
Cows, buffaloes : 200 ml to 300 ml
Ewes, doe and sows : 30 ml to 50 ml

PRESENTATION
Miphocal is available in multidose Bottles of 450 ml.
 BACK
TO

Bovoplex-C.C. PRODUCT
RANGE

(Vitamin B complex with Liver Extract & Choline Chloride)

DESCRIPTION
A dark brown injectable solution containing B complex, Vitamins, Liver Extract and
Choline Chloride.

COMPOSITION
Each ml contains

Thiamine hydrochloride I.P. 25 mg

Riboflavin Phosphate Sodium I.P. 1.5 mg
Vitamin B6 I.P. 5.0 mg
Niacinamide I.P. 50 mg
Cyanocobalamine I.P. 50 mcg.
Choline Chloride I.P. 25 mg
Phenol (as Preservative) I.P. 0.5% w/v
Liver inj. crude having B12 activity of not less than 2 mcg. Of Cyanocobalamine.

INDICATIONS
Primarily as supportive therapy in conditions leading to liver Dysfunction viz. liver
fluke infestation, fatty degeneration of liver, in the treatment of anorexia and B com-
plex Vitamin deficiency conditions.

ADMINISTRATION
Bovoplex - CC injection should be administered by deep intramuscular route only.

DOSAGE STORAGE
Cattle, buffaloes and horses : 10 ml daily Store in a cool and dark place.
Calves, sheep, goats and pigs : 5 ml daily
Dogs and cats : 2 to 5 ml daily PACK
The treatment should be given for a minimum of 3 days. Bovoplex - CC injection is available in 30 ml vials.
 BACK
TO

Mastect PRODUCT
RANGE

(for detection of mastitis)

Mastect is a booklet of Bromothymol blue impregnated strips of paper.

Mastect is unique and simple aid developed by the National Dairy Development Board,
Anand for detection of clinical / subclinical mastitis by milk examination in dairy animals
under field conditions.

DIRECTIONS OF USE

Clean the udder with water and wipe dry with clean towel before milking.
Interpretation of changed colour should be as follows
Handle MASTECT with dry hands. Yellow Normal

Use a separate strip for each quarter of the udder. Yellowish – Green
Green
Discard first few strippings of milk.
Blue
Tear off a strip from the booklet and put one drop of milk on it. * = Repeat the next day.
Suspected Mastitis *
Subclinical Mastitis
Clinical Mastitis

Observe the immediate colour change, if any. PRECAUTIONS

Mastect should be stored in a dry and dark place.
Compare the colour change with the colour index in the inner side of the booklet’s Mastect may give a false test in ketosis and other similar conditions where milk
cover. composition changes.
 BACK
TO

Xylaxin PRODUCT
RANGE

(Xylazine Hydrochloride Injection)

COMPOSITION
Xylaxin injection (2% Solution) contains Xylazine Hydrochloride 23.22 mg per ml.

INDICATIONS
Xylaxin injection is recommended for inducing sedation and analgesia in various ani-
mals, for restraining of animals for routine observations, minor surgical interventions,
immobilization of animals during transportation and transhipment or any similar func-
tions. It can also be used as a preanaesthetic to general anaesthesia.

ADMINISTRATION
By intramuscular route. For horses intravenous.
Species Dose in mg.per Kg. Body weight Dose per average adult
Cattle 0.1 to 0.2 1.5 to 3.0 ml
Horses 1.0 to 2.0 25.0 to 50.0 ml PRECAUTIONS
Dogs 1.0 to 2.0 0.75 to 1.5 ml After administration of Xylaxin the animal should be left undisturbed as excitement
may reduce the level of sedation. Accidental falls and injury to be avoided during the
Cats 1.0 to 2.0 0.1 to 0.5 ml induction of sedation by keeping the animal under observation after the onset of se-
Sheep 0.1 to 0.3 0.1 to 0.5 ml dation. Caution is required while administering the drug in weak and debilitated ani-
mals.
Goats 0.05 to 0.5 0.1 to 0.75 ml
Camels 0.1 to 0.5 5.0 to 20.0 ml SIDE EFFECTS
Xylaxin is well tolerated in most animals without any side effects. A brief rise in blood
Wild Deers 1.5 to 3.0 2.50 to 4.5 ml
pressure may occur which gradually becomes normal. Sweating and urination in horses,
Elephants 0.1 to 0.4 5.0 to 20.0 ml liquid and soft faeces in cattle, emesis in cats and dogs are some of the effects. The
drug is rapidly excreted from the body.
CONTRA-INDIACATIONS
Xylaxin should not be used in conjunction with tranquilizers or neuroleptic drugs. Ani- ANTIDOTE
mals in the last term of pregnancy should not be given the drug as it may induce early Yohimbine hydrochloride and 4-amino pyridine are the antidotes for Xylaxin.
parturition or abortion. Cats and dogs with oesophageal obstruction, intestinal torsion
or hernia as well as animals with pulmonary disorders should not be injected with PRESENTATION
Xylaxin. Xylaxin is available in 30 ml. Vials.
 BACK
TO

Trophovet PRODUCT
RANGE

(Pregnant Mare Serum Gonadotrophin BP (Vet))

Trophovet is capable of supplementing and can be used in place of Follicle Stimulating Hormone of the anterior pituitary
gland. Trophovet stimulates development of the ovarian follicle in the female and has spermatogenic activity in the male
by its effect on the seminiferous tubules.

DESCRIPTION
Trophovet is presented as a freeze-dried product containing 5000 I.U. Pregnant Mare Serum Gonadotrophin BP (Vet)
together with diluent.

DOSAGE AND ADMINISTRATION

SPECIES INDICATION DOSAGE AND ADMINISTRATION

Mare Anoestrus 3000 to 6000 IU i.m./s.c. followed by HCG
1500 to 3000 IU at the time of Service.
Cattle Anoestrus, Superovulation 500 to 1000 I.U. i.m., 1500 to 3000 IU i.m.
between 8 to 13 days of the cycle.
Bitch Induction of oestrus Daily s.c. inj. of 500 IU or 20 IU/kg body wt.
For 10 days. Inject 500 IU HCG on day 10.
Ewe Induction of oestrus & synchronization 400 to 700 IU i.m. after removal of vaginal
sponges containing Progesterone.
Male Animals
Bull Impaired spermatogenesis 1000 IU to 3000 IU i.m. twice weekly for 4 to 6 weeks.
Ram / Buck Impaired spermatogenesis 500 to 750 IU i.m. twice weekly for 4 to 6 weeks.
Dog Impaired spermatogenesis 400 to 1000 IU i.m. twice weekly for 4 to 6 weeks.
Following reconstitution with the 5 ml diluent, each ml will contain 200 I.U. Normal In rare cases, anaphylactic reactions may be seen as with all protein preparations.
aseptic precautions should be observed while injecting. Adrenaline injection is the standard treatment. Corticosteroids can also be used.

CONTRA-INDICATIONS STORAGE AND TRANSPORT

Since multiple ovulation occurs following administration of TROPHOVET, it is not Store and transport between 2° and 8°C.
advisable to permit service or insemination during the first heat produced, except
when used specifically for it. PRESENTATION Freeze-dried preparation : 1000 I.U. Vial.
Diluent : 5.0 ml. Vial.
For the use of a Registered Medical Practitioner or a Hospital or a Laboratory Only.
RABIES VACCINE B.P 'Rab/Vac' 1 dose for Human Use
Purified Vero Cell Rabies Vaccine
Abhayrab
Purified Inactivated Rabies Vaccine prepared on Vero cells. For the prophylactic or
post exposure immunization. Prepared using L.Pasteur 2061/Vero Rabies strain.
Clinical studies with Abhayrab shows neutralizing antibody responses both after primary
and secondary immunizations.
COMPOSITION PER SINGLE DOSE
Freeze-dried Vaccine : 1 immunizing dose contains the protective activity of equal to
or greater than 2.5 International Units (IU) even after exposure at 37oC for one month.
Rabies Virus (L.Pasteur 2061/VERO) propogated on Vero cell line inactivated with
beta-propiolactone. Thiomersol @ 0.01% added as preservative.
Maltos : q.s. per immunizing dose.
Human Serum Albumin : q.s. per immunizing dose.
The antibiotics Neomycin, Kanamycin and Polymixin B sulphate used in the cell and
virus cultures are eliminated to the greatest extent during purification procedures and
cannot be detected in the final vaccine.
INDICATIONS
- For active immunization against Rabies both for prophylaxis and post-bite therapy
in all age groups of humans
- For immunizing against Rabies after exposure (after contact with a rabid or
suspected rabid animal). See Table-1 for W.H.O. recommendations
- For prophylactic immunization of all high risk group of persons such as
Veterinarians, Municipal workers, Medical and Paramedical personnel, Forest
and Zoo personnel, Hunters, Laboratory personnel working with suspected
Rabies materials and Pet owners.
DOSAGE
Prophylaxis: Three immunizing doses on 0, 7 and 21 or 28 days followed by annual
booster. Post-Exposure: One immunizing dose on post exposure days 0, 3, 7, 14, 28
and 90 each.
BACK
TO
PRODUCT
RANGE
ADMINISTRATION
Reconstitute the freeze-dried vaccine with the diluent supplied along with the vaccine.
Administer the reconstituted vaccine (entire quantity of the vial) by deep intramuscular
route in the deltoid region or by subcutaneous route. The reconstituted vaccine is to
be used immediately and shall not be stored for administration later.
INCOMPATIBILITIES
None
CONTRAINDICATIONS
Post-exposure immunization
As Rabies is a dreaded disease; no contraindications are to be considered in case of
post-bite therapy.
Pre-exposure immunization
In case of pregnancy or acute febrile illness, the vaccination should be postponed.
SPECIAL CONDITIONS
Use In Pregnancy
Pregnancy Category C. Animal reproductive studies have not been conducted with
Abhayrab. It is also not known whether Abhayrab can cause fetal abnormalities when
administered to a pregnant women or can affect reproduction capacity. Abhayrab should
be given to a pregnant women only If clearly needed.
Use In Lactation: - As Rabies is always fatal in humans, there are no contraindications.
It can be used in lactation in case of suspected rabid contamination.
Use In Children's: - As Rabies is always fatal, there is no age limitation. It can be used
in all ages of children's in case of suspected rabid contamination.
CAUTIONS
1. Concurrent use of immunosuppressive agents like corticosteroids shall be avoided
as it may hamper in the development of protective antibodies.
2. In case of severe bites and at the site of injuries, nearer to head local infiltration of
the wounds with antirabies immunoglobulins is recommended.
3. Delay in the commencement of post-bite therapy, incomplete and irregular therapy
can cause failure of protection.
Continued
 BACK
TO
PRODUCT
RANGE

STORAGE
Table 1 Guide for post exposure treatment (W.H.0. Recommendations)
To be stored at temperatures between +2OC to +8OC. Do not freeze.
Category Type of contact with the Course of action to be followed
PRESENTATION
suspected or confirmed
Box of 1 dose vial along with Diluent Ampoule (0.5 ml), Sterile disposable syringe with
rabid animal
needle and vaccination card.
I Touching or feeding of animal, None, if reliable case history
Rabies Antiserum I.P
licks on intact skin available
AbhayRIG
II Nibbling of uncovered skin, Administer vaccine immediately.
minor scratches or abrasion Stop the treatment if the
without bleeding, licks on animal remains healthy for
broken skin a period of 10 days or
has been killed humanely
and found to be negative for
Rabies by appropriate laboratory
techniques.

III Single or Multiple transdermal Administer rabies

bites or scratches with saliva
(i.e.licks)
immunoglobulins and
vaccine immediately.
Stop treatment if the animal
remains healthy throughout the
observation period of 10 days or
if animal is killed humanely and
found to be negative for rabies by
appropriate laboratory
techniques.

Back
For The Use Of Registered Medical Practioner Or Hospital Or Laboratory Only
BACK
TO

Abhay RIG PRODUCT

RANGE

Rabies Antiserum I.P

COMPOSITION and vaccine. Anti rabies vaccine should be inoculated in different parts of the body
Each vial contains contra-laterally if possible. In this case interference is minimized. AbhayRIG should
Equine antirabies immunoglobulin fragments not less than 300 I.U/ml. not be administered in the same syringe as the vaccine.
Cresol I.P = 0.25% v/v as a preservative
Glycine I.P --------------------------------------------------------- 0.0225 g/ml PREGNANCY AND LACTATION
Sodium Chloride I.P -------------------------------------------- 0.009 g/ml The safety of AbhayRIG when used during pregnancy has not been established in
Water For Injection I.P ----------------------------------------- q.s clinical trials in human beings. Considering the lethal risk associated with rabies,
Pregnancy is not a contraindication to the administration of AbhayRIG subsequent to
PHARMACEUTICAL FORM exposure to rabid animal.
Solution for injection by intramusclar route 5 ml vial, 1500 IU
Table: Guide for Post Exposure Treatment
THERAPEUTIC INDICATION
AbhayRIG provides passive immunization against rabies. AbhayRIG is indicated for Category Type of contact with the Recommended Treatment
the prevention of rabies in patients at risk of being exposed to rabies after contact with suspected or confirmed
a rabid animal or an animal presumed to be rabid. domestic or wild animals or
AbhayRIG itself does not constitute an antirabies treatment and should always be Animals unavailable for
observations
used in conjuction with rabies vaccine.
I Touching or feeding of animal, None, if reliable case
CONTRAINDICATIONS licks on intact skin history available
Should be used with extreme caution in subject with a history of allergic symptoms or
hypersensitivity to horse serum. In case of doubt, it is essential to ask your doctor or II Nibbling of uncovered skin, Administer vaccine immediately. Stop the
pharmacist for advise. minor scratches or abrasion treatment if the animal remains healthy
without bleeding, licks for a period of 10 days** or has been
SPECIAL WARNINGS AND PRECAUTIONS FOR USE on broken skin killed humanely and found to be negative
Despite the high degree of purification of the serum. It is recommended to perform a for Rabies by appropriate laboratory
skin test before administering heterologous serum. The skin test consists of intradermal techniques.
injection of 0.1 ml of 1:10 dilution of AbhayRIG on the outside of the forearm so as to III Single or Multiple transdermal Administer rabies immunoglobulins and
obtain an orange ring type appearance (3 mm diameter in duration). An equivalent bites or scratches with saliva vaccine immediately. ** Stop treatment
intradermal injection of physiological saline solution is used as control The observations (i.e.licks) if the animal remains healthy throughout
made 15 minutes after intradermal injection is considered to be positive if erythema the observation period of 10 days***
(>6mm), local oedema or a systemic reaction is observed and the control is negative. or if animal is euthanised and found
A positive test result is not a formal contraindication for the use of seropathy, but it to be negative for rabies by appropriate
should be considered as a warning. A negative test is not an absolute guarantee for laboratory techniques.
the absence of an immediate allergic type reaction.
** If an apparently healthy dog or cat in or from a low risk area is placed under
DRUG INTERACTIONS observation it may be justified to delay specific treatment.
*** This observation applies only to dogs and cats.
Rabies prevention requires simultaneous administration of antirabies immunoglobulin
Continued

IMPORTANT NOTES
ACTION
Washing the wound copiously
with soap and water
Application of 70% alcohol,
tincture of iodine, povidine
iodine or any other suitable
disinfectant (after all traces of
soap have been removed)
Proper infiltration of the wound
with rabies immunoglobulin (RIG)
of Human or Equine orign. As
much as anatomically feasible
should be infiltrated into and
around the wound and the
remaining. If any to be injected
(by intramuscular route only) in
the deltoid region away from
the site of vaccine
administration
Administration of potent cell
culture vaccine as per
recognized schedules
RESULTS
Helps reduce the viral load
by physically removing virus particles
(with running water) and subsequently by
inactivating some of the remaining virions by
chemical disruption. This simple action,
if promptly carried out, can significantly
reduce the risk of developing rabies.
Alcohol or other disinfectants
lead to further inactivation
of the remaining virions by
chemical disruption.
RIG is a specific-rabies-virus-neutralising
antibody that immediately neutralizes
the rabies virus on contact. Once
the viruses are coated with antibody.
They can not absorb onto and enter
the nerve endings. This results in a further
reduction (and in some cases complete
obliteration) of the inoculated virus.
Even in deeper tissues where the
soap or alcohol may not have reached.
Potent cell culture vaccine when
administered according to the approved
schedules results in the systemic production
of anti-rabies antibodies after a lag period of
7 to 14 days. These circulating antibodies
reach the wound site through the systemic
circulation and are able to neutralize
any remaining virus particles.
BACK
TO
PRODUCT
RANGE
FIRST-AID TREATMENT
All the areas of the site of the bite or scratch site which may be infected with rabies
virus should be immediately and thoroughly washed with soap or detergent with running
water and 70% alcohol or an iodine preparation is applied AbhayRIG should be injected
as soon as possible in case of suspected exposure.
DOSAGE AND ADMINISYTRATION OF AbhayRIG
For the prevention of rabies, combined immunoglobulin and rabies vaccine treatment
is recommended for all category III exposure as per WHO classification of exposure.
The recommended dose of AbhayRIG is 40IU/Kg of the body weight, if anatomically
feasible, as much as possible of the dose should be infiltrated around the wounds.
Administer the remainder of the dose, if any by deep intramuscular injection at a site
separate from that used for the vaccine. Ensure that the wound has been adequately
infiltrated with immunoglobulin locally before suturing, if suturing is necessary. The
first dose of the vaccine should be inoculated at the same time as that of AbhayRIG,
but at a different site on the body. In no cases should the dosage of AbhayRIG be
exceeded because immunoglobulin may partially suppress active production of
antibodies. Children and adults receive the same dose of 40 IU/Kg of body weight. In
case the volume of AbhayRIG is low or insufficient for infiltration in case of child or in
case of large bite site then it can be diluted in normal saline. When indicated, begin
anti tetanus treatment and administer anti microbial drugs to control infections other
than rabies. Discard any unused portion.
UNDESIRABLE EFFECTS
Immediate or delayed hypersensitive type reactions may be developed on
administration of AbhayRIG. The observed immediate reactions are anaphylactoid
reactions with hypertension, dyspnoea and urticaria. Delayed reactions consist of
inflammatory reaction, fever, pruritis, rash or urticaria, adenopathy and arthralagia.
Inform your doctor or pharmacist if you experience any undesirable effect.
STORAGE CONDITIONS
Store at a temperature between 2oC and 8oC in a refrigerator. DO NOT FREEZE.
PRESENTATION
Vials of 5 ml. Each vial contains not less than 1500 IU of equine antirabies
Immunoglobulin.
Back

MEASLES, MUMPS AND RUBELLA VACCINE E.P
Live, Attenuated, Freeze-dried
Abhay-Vac 3
DESCRIPTION
The vaccine is prepared from live, attenuated viruses, measles (Edmonston-Zagreb
strain) and rubella (RA27/3 strain) grown in human diploid cells (HDC) and mumps
(L-Zagreb strain) grown in cell culture of freezed dried vaccine dissolved with sterile
water for injections enclosed. The dissolved vaccine is clear yellow to clear pink shade.
When reconstituted as directed, each single human dose (0.5ml) contains not
less than
-1000 CCID50 of measles virus.
-5000 CCID50 of mumps virus.
-1000 CCID50 of rubella virus.
Inactive ingredients (Stabilizers) are: sorbitol, gelatin, L-arginin, maltose, sodium
chloride, lactalbum hydrolysate and L-alanin.
The production and control of measles, mumps and rubella vaccine (live) satisfies
national requirements and the respective monograph of European pharmacopoeia
(3rd Edition)
INDICATIONS
The combined vaccine induces active protection against several infectious diseases
i.e measles, mumps and rubella. The vaccine should be used at the age when children
lose their passive protection by maternal antibodies for an optimal immunoreaction to
be achieved by immunization.
On immunization with the combined measles, mumps and rubella (MMR) vaccine,
according to the two dose vaccination protocol, most children and adolescents presently
receive two doses of the measles, mumps, rubella vaccine. The first dose is
recommended to be given at the age of 12-15 months. The second dose of MMR
vaccine should be routinely administered at the age of 6-7 years.
DOSAGE AND ADMINISTRATION
A vaccine dose is 0.5 ml. The freeze-dried vaccine should be dissolved immediately
before use. A sterile needle and syringe should be used to draw the indicated amount
BACK
TO
PRODUCT
RANGE
of water for injection and to inject it into the vial with freeze-dried vaccine. Five vaccine
doses are dissolved in 2.5 ml water for injection.
Shaking the content gently to avoid the formation of foam, the vaccine is quickly
dissolved, forming a homogenous suspension. Before vaccination, the vaccine should
be warmed to body temperature by holding it in hand. Care must be taken for the
vaccine not to come in contact with the disinfectant. The vaccine should be
subcutaneously injected in the upper arm, in the deltoid region. In case of multi dosage
packages, a new sterile syringe and needle must be used with each individual dose.
Microbiologically, the vaccine should be used immediately upon package
opening. If the vaccine is not used immediately, the user is responsible for the time
and storage of open vaccine. Dissolved vaccine can be stored for a maximum of 8 hr
at +2o C to +8oC, unless the vaccine has been opened and dissolved under controlled
and validated aseptic conditions.
ADVERSE REACTIONS
Local
Transient pain and irritation (edema, induration, erythema) at the site of injection.
General:
Side effects usually restricted to the individuals sensitive to some of the vaccines
components have been recorded in 5-15% of subjects vaccinated with MMR vaccine
after the first dose. Elevated body temperature occurring (Approximately) a week after
the vaccination, and rash are the most common reactions to vaccination with a live
attenuated measles virus. Rare reactions to mumps component manifest as elevated
body temperature, swollen parotid glands and rash. Side effects associated with the
rubella component are related to the vaccinee’s age: arthralgia and arthritis after
immunization are reported in the older groups of vaccinated girls.
CONTRAINDICATIONS AND SPECIAL WARNINGS
Vaccination is contraindicated in the following states
- Febrile state
- Pregnancy
- immunodeficiency and immunosupression (primary and secondary caused by
malignant diseases or use of drugs such as antimetabolites, corticosteroids,
Continued
 BACK
TO
PRODUCT
RANGE

alkilating compounds and irritation)

- Within three months from blood or plasma transfusion or immunoglobulin therapy,
or within six months from exsanguinal transfusion.
- hypersensitivity to the vaccine ingredients

Diarrhea and mild acute diseases of the upper respiratory tract as well as HIV
seropositive are not contraindications for the use of vaccines.

Before immunization, through history must be taken. The children in higher risk of
infectious diseases should be vaccinated in separate. They include the children with
asthma, cystic fibrosis, celiac diseases, chronic pulmonary diseases, congenital cardiac
diseases, Down syndrome, stable neurological status, malnutrition, and premature
irrespective of the grade of prematurity.
At least one month should elapse between the uses of two live viral vaccine, if not
simultaneously administered. Tuberculin test (Mantoux test) should be performed before
or two months after vaccination against measles, MMR, because of the vaccine may
induce transient inhibition of cellular immunity. The MMR vaccine can be administered
simultaneously with other live viral vaccines (diphtheria, tetanus and pertusis vaccine)
without interfering any component immunogenicity.
On simultaneous administration, mixing of other vaccines with measles, mumps and
rubella vaccine in the same syringe is not advised.
Keep adrenalin injection ready in case of anaphylactic shock.

STORAGE
The vaccine should be protected from light and stored at a temperature of +2oC to
+8oC

SHELF LIFE
The expiration date of the freeze dried vaccine is 24 months from the last date of
initiation of potency test.

PRESENTATION
5 dose vials plus ampoule with diluent (2.5 ml)

Back

MEASLES VACCINE E.P
Live, attenuated, freeze-dried
Abhay-M
DESCRIPTION
The vaccine is prepared from live, attenuated measles virus ((Edmonston-Zagreb
strain ) grown in human diploid cells (HDC).
Freeze-dried vaccine is dissolved with sterile water for injections enclosed. The
dissolved vaccine is yellow to clear pink shade.
When reconstituted as directed, each single human dose (0.5ml) contains not less
than: -1000 CCID50 of measles virus
Inactive ingredients (stabilizers) are: sorbitol, gelatine, L-arginin, maltose, sodium
chloride, lactalbumin hydrolysate and L-alanin.
The production and control of measles vaccine (live) satisfies national requirements
and the respective monograph of European Pharmacopoeia (3rd ed.)
INDICATIONS
The vaccine induces active protection against measles. The vaccine should be used
at the age when children lose their passive protection by maternal antibodies for an
optimal immunoreaction to be achieved by immunization.
A single dose of measles vaccine is sufficient to provide prolonged immunity to infection.
In countries where the incidence and mortality from measles in the first year of life is
high, the recommended age for Immunization is as soon as possible after 9 months of
age. Countries where measles are lss of a problem may decide to immunize later.
DOSAGE AND ADMINISTRATION
A vaccine dose is 0.5ml. The freeze-dried vaccine should be dissolved immediately
before use. A sterile needle and syringe should be used to draw the indicated amount
of water for injection and to inject it into the vial with freeze-dried vaccine. Ten vaccine
doses are dissolved in 5.0ml water for injection.
Shaking the content gently to avoid the formation of foam, the vaccine is quickly
dissolved, forming homogenous suspension. Before vaccination, the vaccine should
be warmed to body temperature by holding it in hand. Care must be taken for the
vaccine not to come in contact with disinfectant. The vaccine should be administered
subcutaneously in the upper arm, in the deltoid muscle region. In case of multi-dosage
packages, a new sterile syringe and needle must be used with each individual dose.
Microbiologically, the vaccine should be used immediately upon package opening.
BACK
TO
PRODUCT
RANGE
If the vaccine is not used immediately, the user is responsible for the time and storage
of open vaccine. Dissolved vaccine can be stored for a maximum of 8 hr at + 20 C to
+80 C, unless the vaccine has been opened and dissolved under controlled and
validated aseptic conditions.
ADVERSE REACTIONS
Mild adverse events:
Within 24 hours of vaccination, recipients may experience transient pain and irritation
at the site of injection. Mild systemic reactions may also occur like moderate fever,
which occurs in 5-15% of recipients and rash, which occurs in approximately 2% of
vaccines. The rash typically occurs 7-10 days after the vaccination and lasts 2 days.
Severe adverse events:
Hypersensitivity reactions, including urticaria at the injection site, rarely occur.
Anaphylactic reactions are extremely rare( 1 to 2 per million doses of measles vaccine)
and could be caused by allergy to gelatine , a stabilizer used in vaccine production.
The risk of post-vaccination encephalitis/encephalopathy is less than one per million
doses of measles vaccine, which is 1000 times less than th erisk from natural measles
infection. Measles vaccination reduces the occurrence of subacute sclerosing
panencephalitis. On rare occasions use of a measles – containing vaccine can cause
febrile seizures. There are no scientifically based results, which can prove the
association between measles vaccination and inflammatory bowel disease and autism.
CONTRAINDICATIONS
Vaccination is contraindicated in the following states:
- febrile state,
- pregnancy,
- immunodeficiency and immunosupression (primary or secondary caused by
malignant diseases or use of drugs such as antimetabolics, corticosteroids, alkilating
compounds and irradiation)
Within three months from blood or plasma transfusion or immunoglobin therapy, or
within six months from exsanguinal transfusion.
Hypersensitivity to vaccine ingredients
Diarrhea and mild acute diseases of the upper respiratory tract as well as HIV
Continued
 BACK
TO
PRODUCT
RANGE

seropositivity are not contraindications for the use of vaccine.

Before immunization, thorough history must be taken. The children in higher risk of
infectious diseases should be vaccinated in separate. They include the children with
asthma, cystic fibrosis celiac diseases, chronic pulmonary diseases, congenital cardiac
diseases. Down syndrome, stable neurological status, malnutrition, and premature
irrespective of the grade of prematurity.
At least one month should elapse between the uses of two live viral vaccines, if not
simultaneously administered. The measles vaccine can be administered simultaneously
with other live viral vaccines (poliomyelitis, hepatitis B and yellow fever vaccine) and
bacterial vaccines (diphtheria, tetanus and pertussis vaccine) without interfering with
any component immunogenicity. On simultaneous administration, mixing of other
vaccines with measles, vaccine in the same syringe is not advised. Tuberculin test
(Mantoux test) should be performed before or two months after vaccination against
measles, because the vaccine may induce transient inhibition of cellular immunity.
Keep adrenaline injection ready in case of anaphylactic shock.

STORAGE
The vaccine should be protected from light and stored at a temperature of +2oC to
+8oC

SHELF LIFE
The expiration date of the freeze - dried vaccine is 24 months from the last date of
potency test.

PRESENTATION
10 dose vials plus ampoule with diluent (5.0ml)

Back
For The Use Of Registered Medical Practioner Or Hospital Or Laboratory Only
BACK
TO

Abhay-MTM Vaccine, (I.P.) PRODUCT

RANGE

DESCRIPTION - Known Allergy to any component of Abhay-MTM

The freeze-dried measles vaccine vial contains live attenuated measles virus - Severely compromised renal function.
(Edmonston-Zagreb strain) propagated on human diploid cells (MRC-5). The freeze - Decompensated cardiac status.
dried measles vaccine is a white or nearly white pellet. - CNS Disorders.
- Pregnancy.
POTENCY - Individuals with blood dyscrasias, lymphomas, or other generalized malignancies.
Each does of 0.5ml contains - individuals undergoing treatment with immuno suppressive agents of any kind or
Active lngredients: with primary immunodeficiency.
Not less than 1000 CCID50 of measles virus
Other Ingredients: WARNINGS
2.5% of gelatin. - If Abhay-MTM is used in persons who are otherwise immunocompromised,
5% of sorbiol. the expected immune response may not be obtained.
When reconstituted with the provided diluent (Sterile water for Injection)it yields a - Administration of the vaccine should be deferred at least 3 months after ad-
clear suspension for injection. ministration of human immunoglobulin, plasma or whole blood. If repeated or
large amounts of these substances have been given, a longer interval should
CLINICAL PHARMACOLOGY be allowed.
Measles is a common childhood disease, caused by the measles virus that may be - Administration of attenuated live virus measles vaccine may temporarily de
associated with serious complications and or death. For example, pneumonia and press tuberculin skin sensitivity. Therefore, if tuberculin test is to be done, it
encephalitis are caused by measles. Abhay-MTM generates specific protective im- should be scheduled before administering measles vaccine or on the day of
mune response against measles. vaccination with reading 48 to 72 hours later. Otherwise, it should be post
poned for 4 to 6 weeks. This avoids the possibility of a false negative re
INDICATIONS AND USAGE sponse. Although tuberculosis may be exacerbated by natural measles in
- For active immunization of all susceptible children at 9 months of age or at fection, there is no evidence that measles vaccine has such effect.
the earliest thereafter.
- Measles vaccine is also recommended for children and adolescents who have PRECAUTIONS
never had documented measles or who have received live attenuated vac - Extreme caution should be exercised if the vaccine is administered to per
cine before the age of 12 months. sons with a history of anaphylactic reactions and/thrombocytopenia.
- Persons of any age known to be sero-negative. - The possibility of allergic reactions in individuals sensitive to components of
- Minor illness, such as the common cold are not a contraindication to immuniza the vaccine should be evaluated. Epinephrine HCI solution (1:1000) should be
tion. available for immediate use in case an anaphylactic or acute hypersensitivity reac
tion occurs.
CONTRAINDICATIONS
- Acute febrile illness.

Continued
 BACK
TO
PRODUCT
RANGE

UNDESIRABLE EFFECTS - Carefully insert the needle into the subcutaneous tissue.
Abhay-MTM is generally well tolerated. Adverse events include
LOCAL: IMMUNIZATION REGIMEN
Erythema and/or swelling around the site of injection.
SYSTEMIC: Primary-Immunization Schedule
Fever starting 5-12 days after vaccination, Rash, Seizures, Thrombocytopenia and 1st Dose 9-12 months
Encephalopathy have been reported to be associated with measles vaccination.
2nd Dose (As MMR) 15-18 months
DOSAGE AND ADMINISTRATION Dose for children out of step 2 MMR doses separated by an
DOSAGE: with schedule and older interval of at least 4 weeks.
One dose (0.5ml) of Abhay-MTM at 9 months of age, or as soon as possible there after than one year.
followed by MMR Vaccine at 15-18 months is recommended.
ADMINISTRATION:
IMMUNIZATION IN SPECIAL SITUATIONS
The vaccine should be administered by subcutaneous injection near the insertion of
Pregnancy: Abhay-MTM should not be administered to pregnant woman and preg-
the deltoid muscle. The vaccine must not be injected intravenously. The site of the
nancy should be avoided for four weeks following vaccination.
injection should be prepared with a suitable antiseptic.
PHARMACEUTICAL PARTICULARS
CAUTION:
Incompatibilities
A new sterile disposable syringe should be used for each dose of the vaccine.
The EPI recommends simultaneous administration of measles vaccine with other EPI
WITHDRAWING THE STERILE DILUENT FROM A SEALED GLASS AMPOULE:
vaccines.
Tap the ampoule to ensure that the diluent is in the lower portion, wipe the neck of the
lower portion and wipe the neck of the ampoule with a suitable antiseptic. Snap off
SHELF LIFE
the top of the ampoule. With a sterile syringe and needle withdraw the required
Two years from the date of manufacture.
volume of sterile diluent from the ampoule.
PRESENTATION
RECONSTITUTION OF FREEZE DRIED VACCINE:
Abhay-MTM Single dose and Multidose freeze-dried measles vaccine is presented in
- Remove the flip off.
amber colored vials.
- Do not remove tha rubber stopper from the vial.
- Single dose vial of lyophilized vaccine.
- Apply a piece of cotton with a suitable antiseptic to the surface of the rubber
- Five dose vial of lyophillzed vaccine.
stopper of the vial and inject the sterile diluent into the vial gently.
- Ten dose vial of lyophilized vaccine.
- Roll the vial gently between both palms to allow dissolution of the pellet without
Special Precautions for Storage
formation of foam. Withdraw the required dose (0.5ml) of the reconstituted
The Abhay-MTM vaccine vial must be stored in the dark at or below +80C. The Diluent
vaccine into the syringe.

Continued
 BACK
TO
PRODUCT
RANGE

(sterile water for injection) should not be frozen but should be kept cool. It is important
to protect both the lyophilized and reconstituted vaccine from light.
Instructions for use and handling
Sterile disposable syringe free of preservatives, antiseptics and detergents should be
used for each injection and/or reconstitution of the vaccine. A 25 guage, 5/8'' needle
is recommended.
The vaccine should preferably be used immediately after reconstitution. The
unused reconstituted vaccine must be stored at +2o C to +8o C and used within
8 hours otherwise it must be discarded.

Back
For The Use Of Registered Medical Practioner Only
Elovac - B®
Hepatitis B Vaccine B.P(r DNA)
DESCRIPTION
Elovac-B® (Recombinant Hepatitis - B vaccine) is a noninfectious recombinant DNA
vaccine. It is a sterile suspension of purified major surface antigen of Hepatitis B virus
(HBV). The Hepatitis B surface antigen (HBsAg) is produced from cultures of geneti-
cally engineered Pichia pastoris, containing the gene that codes for the HBsAg. The
HBsAg protein released by disruption of Pichia pastoris cells is purified by various
physiochemical methods. The purified antigen is adsorbed on Aluminium hydroxide
gel to get bulk vaccine. The vaccine does not contain any material of human or animal
origin.
Elovac-B® is commercially available as a sterile suspension, ready to use for
I.M.injection. The vial must be shaken well before administration.
Paediatric & Adolescent dose: Each 0.5ml dose contains 10mcg of Hepatitis B
surface antigen (purified) adsorbed on 0.25mg Aluminium as Aluminium hydroxide
and 0.025mg of Thiomersal as preservative.
Adult dose
Each 1 ml adult dose contains 20 mcg of Hepatitis B surface antigen (purified) adsorbed
on 0.5 mg Aluminium as Aluminium hydroxide and 0.05mg of Thiomersal as
preservative.
CLINICAL PHARMACOLOGY
Elovac-B ® generates specific protective immune response against HBsAg. For
protection against HBV infection the anti-HBsAg titre (Anti-HBs antibodies) should be
more than or equal to 10 mlU/ml.
INDICATIONS AND USAGE
Elovac-B® Vaccine is indicated for immunization against infection caused by all known
subtypes of Hepatitis B virus.
Routine vaccination
New born, infants, children and adolescents.
Vaccination of defined high risk populations
High risk populations
1. People who have a job that involves contact with human blood (Ex: Health care
BACK
TO
PRODUCT
RANGE
personnel, Military personnel etc.).
2. Travelers to area where Hepatitis B is common.
3. Injectable drug abusers.
4. Patients who may require multiple blood transfusions.
5. Persons originating from areas of high endemicity.
6. Persons who have sex with someone infected with HBV
7. Persons who have sex with more than one partner.
8. Men who have sex with men.
9. People who live in the same house with someone who has chronic HBV infection.
10.Infants born to HBV positive mothers.
CONTRAINDICATIONS
Elovac-B® Should not be administered to any person who has experienced a hyper-
sensitivity reaction to any component of any Hepatitis B recombinant DNA vaccine.
Elovac-B® Should not be administered to subjects with severe febrile infections.
WARNINGS
Elovac-B® may not prevent infection, if the vaccinee, at the time of immunization was
harboring an unrecognized Hepatitis B infection.
Not all vaccinees respond in the same manner to a given vaccine. The immune
response may be dependant upon many factors. Some are mentioned below. Age
over 40 years, Gender: Male, Smokers, Obese individuals, patients with immunodefi-
ciency diseases or those receiving immuno-suppressive therapy or those who
received the vaccine on the gluteal region, may have an unsatisfactory antibody titre.
Hence adequate anti-HBs antibody titres may not be obtained after a primary course
of immunization.
In such persons additional doses of the vaccine may be required.
The vaccine does not prevent infection by Hepatitis A, Hepatitis C, Hepatitis D,
Hepatitis E or other pathogens known to infect the liver.
Pregnancy:
Adequate human and animal data on use during pregnancy is not available.
Hepatitis B vaccine should be used during pregnancy only when definitely indicated,
Continued

and the possible benefits outweigh the possible risks to the foetus.
However as with all inactivated viral vaccines we don't anticipate any harm to the
foetus.
Lactation:
Adequate human and animal data on use during lactation is not available. Caution
should be exercised when Hepatitis B vaccine is administered to lactating women.
Patients who develop symptoms suggestive of Hypersensitivity after an injection should
not receive further injections of the vaccine.
Interactions with other vaccines
Elovac-B® vaccine can be administered concomitantly with DPT, TT, DT, and OPV, if
required.
Elovac-B® vaccine can be given together with Measles-Mumps-Rubella vaccines,
Haemophilus influenza B vaccine, Hepatitis A vaccine and BCG vaccine.
Different injections should be given at different sites using separate needles and sy-
ringes.
Interchangeability with other Hepatitis B vaccines
Elovac-B® can be used for primary vaccinations as well as for booster doses.
Even if the person has been vaccinated by any other Hepatitis B vaccine, the subse-
quent vaccination series may be continued using Elovac-B®
PRECAUTIONS
- Caution and care should be exercised in administering the Vaccine to individuals
with severe compromised cardiopulmonary status as systemic reaction could pose
a significant risk
- As with any injectable vaccine, epinephrine should be available for use in case of
anaphylaxis or anaphyiactic reaction.
- The vaccine should be well shaken before use.
- In presence of minor infection Elovac-B® to be used only when clearly needed
and the possible advantage outweighs the possible risks.
UNDESIRABLE EFFECTS
Most common undesirable effects:
Injection site: Mind soreness, indurations and erythema.
BACK
TO
PRODUCT
RANGE
Uncommon undesirable effects classified by body system:
SYSTEMIC: Fatigue, low-grade fever and malaise.
SKIN AND APPENDAGES: Rash, pruritis and urticaria.
MUSCULOSKELETAL SYSTEM: Arthralgia and myalgia.
DIGESTIVE SYSTEM: Nausea, vomiting, diarrhoea and abdominal pain.
HEPATOBILIARY SYSTEM: Abnormal liver function tests.
NERVOUS SYSTEM: Dizziness and paresthesia.
Extremely rare undesirable effects classified by body system:
SYSTEMIC: Anaphylaxis, serum sickness, angioedema and erythema multiforme.
MUSCULOSKELETAL SYSTEM: Arthritis.
CVS: Syncope and hypotension.
NERVOUS SYSTEM: Neuropathy, neuritis (including Guillain - Barre' syndrome,
opticneuritis), encephalitis and meningitis.
RESPIRATORY SYSTEM: Bronchoconstriction like symptoms.
LYMPHOID SYSTEM: Lymphadenopathy.
DOSAGE AND ADMINISTRATION DOSAGE:
- NEONATES AND CHILDREN TILL THE AGE OF 19 YEARS:
The recommended dose of Elovac-B® is 10mcg of antigen protein in 0.5ml sus
pension.
- ADULT OVER THE AGE OF 19 YEARS:
The recommended dose of Elovac-B® is 20mcg of antigen protein in 1ml sus
pension.
- Elovac-B® SHOULD NEVER BE GIVEN INTRAVENOUSLY.
- Elovac-B® Should be injected intramuscularly in the anterolateral thigh for neo
nates and infants.
- Elovac-B® should be intramuscularly in the deltoid for adults.
- Elovac-B® should be not be administered in the gluteal region as the immune
response may be lower.
- Elovac-B® may be administered subcutaneously in patients with severe bleed
ing tendencies (e.g. haemophilics).
Preparation for administration:
- Elovac-B® is presented as a ready to use suspension.
Continued
 BACK
TO
PRODUCT
RANGE

- The vaccine should be shaken well to obtain a homogenous turbid white suspen nization should start immediately after birth and preferably use 0, 1 and 2 months
sion. schedule.
- The vaccine should be used as supplied and no dilution is necessary. - Chronic haemodialysis Patients
- The vaccine should be inspected visually for particulate material or discolouration The recommended dosage of Elovac-B® vaccine is 40 mcg (2ml) using a 0,1,2,
prior to administration. 6 months vaccination schedule. Anti-HBs surveillance every 3-6 months is war
- Sterile needle and syringe should be used for withdrawal of vaccine. ranted so as to maintain the accepted protective level of 10mlU/ml.
- Aseptic techniques should be followed.
- Any vaccine remaining in a single dose vial should be discarded. PRESENTATION
Immunization Regimen: Elovac-B® is presented as a sterile ready to use slightly turbid white suspension for
Primary immunization with Elovac-B® consists of three intramuscular doses. The intra-muscular administration.
second dose given one month after the first and the third dose administered at least Elovac-B® is marked as:
four months after the second dose of Elovac-B® - 0.5ml and 1ml single dose vial.
- 5.0ml and 10.0ml Multi-dose Vial.
Immunization Schedule:
STORAGE:
1st dose Given on fixed date Protect form light.
DO NOT GREEZE. Discard vial if contents are frozen.
2nd dose 4-10 weeks after the 1st dose
Elovac-B® Must be stored and transported between +2o C & + 8o C.
3rd dose 4-20 weeks after the 2nd dose Elovac-B® Must not be diluted to administer.
A booster dose is recommended 12 months
after the 1st dose.
A second booster dose may be required after
8 years in the high risk population if the
antibody titre falls below 10 mIU/ml.

Immunization in special situations

- Known/presumed exposure to HBV
First dose of Elovac-B® vaccine can be administered simultaneously with Hepa
titis B immunoglobulin, which however must be given at a separate injection site.
- Neonates born to HBV carrier Mother
First dose of Elovac-B® vaccine can be administered simultaneously with Hepa
titis B immunoglobulin, which must be given at separate injection site. The immu

Back
For The Use Of Registered Medical Practioner Or Hospital Or Laboratory Only
BACK
TO

Abhay-TOXTM PRODUCT
RANGE

Tetanus Vaccine (Adsorbed) I.P.

DESCRIPTION
Abhay - TOXTM Tetanus Vaccine (Adsorbed) manufactured by Human Biologicals WARNINGS
Institute, for intramuscular injection, is a sterile suspension of Aluminium phosphate - Tetanus vaccine should not be given more frequently than once in every ten years
adsorbed tetanus toxoid in isotonic sodium chloride solution. The vaccine, after for person with wound who has experienced severe Arthus type hyper sensitivity
shaking, is a turbid liquid, whitish in colour. during the previous dose.
- Pregnant Woman if infected with malaria, the transplacental transfer of antitoxin
COMPOSITION may be impaired.
Each dose of 0.5ml contains: Pregnancy: There is extensive human experience in the administration of Tetanus
Active Ingredients: Vaccine products and there is no evidence of teratogenicity.
Tetanus toxoid > 5 Lf to < 25 Lf Lactation: There is no information on the excretion of Tetanus vaccine antigens or
Other ingredients: antibodies in breast milk during breast-feeding; however, it is unlikely that there is
Adsorbed on AIPo4 > 1.5mg passage of the vaccine.
Thiomersal 0.01% as preservative.
PRECAUTIONS
CLINICAL PHARMACOLOGY An antihistamine may be indicated for mild allergic reactions. For anaphylactic
Natural immunity to Clostridium tetani does not occur. The antigen present in tetanus reactions, adrenaline or epinephrine (1 in 1000) may be used.
vaccine is from the formaldehyde treated exotoxin of Clostridium tetani.
Following adequate immunization with tetanus vaccine, it is thought that protection UNDESIRABLE EFFECTS
persists for at least 10 years. Local: Pain at the injection site followed by local redness or swelling and itching at
the injection site is common which subsides without treatment.
INDICATIONS AND USAGE Systemic: Mild to moderate fever may be observed as systemic undesirable effect in
- All Infants 6 to 8 weeks of age or older, all children and all adults should be immu few cases.
nized against tetanus with the primary series of tetanus vaccine and booster injec
tion every 10 years. DOSAGE AND ADMINISTRATION
- Persons at increased risk of receiving lacerations and abrasions through their occu Dosage: 0.5ml Intramuscular. From birth to the age of 7 years every child must receive
pation or recreational activities. at least 5 doses of a TT containing vaccine. Individuals 7 years of age and older who
- Pregnant woman who are not immunized or inadequately immunized. have not been immunized previously against tetanus, the primary immunization se-
- Persons who are injured. ries of Tetanus Vaccine Adsorbed consists of three doses given at intervals of 4 to 8
weeks between the first and second dose and 6 to 12 months between the second
CONTRAINDICATIONS and third dose as recommended by Immunization Practices Advisory
- Patients with a history of systemic hypersensitivity to toxoids or any of the compo- Committee(ACIP2)
nents of the vaccine. Preparation For Administration:
- Infants and children with high fever or acute illness. Shake the vial to disperse the contents thoroughly immediately before withdrawing

Continued
 BACK
TO
PRODUCT
RANGE

each dose of vaccine. The vaccine should be administered deep intra-muscularly into
the deltoid region. A 24 gauge sterile disposable syringe and needle should be used
for each injection.

IMMUNIZATION REGIMEN
Primay Immunization:
Refer under Dosage and administration.
Abhay - TOXTM may be used to complete the primary immunization series for tetanus
in children 7 years of age or older who have received one or two doses of whole cell
pertussis DTR, DTaP and / or DT vaccine. However the safety and efficacy of
Abhay - TOXTM in such children have not been evaluated. Interruption of the
recommended schedule with a delay between doses should not interfere with the
final immunity achieved with Abhay - TOXTM. There is no need to start the series over
again regardless of the time elapsed between doses.
Pharmaceutical Particulars Incompatibilities
Abhay - TOXTM should not be mixed in the same syringe with any other vaccine.

SHELF LIFE
Three years from the date of manufacture.

PRESENTATION
Abhay - TOXTM vaccine is a sterile, whitish turbid, uniform suspension ready for IM
administration.
Abhay - TOXTM is supplied in :
- Single dose rubber stoppered glass vials.
- Multi dose rubber stoppered glass vials.
Special precautions for storage
Protect from light
DO NOT FREEZE Discard vial if contents are frozen. Abhay - TOXTM must be stored
and transported between 2oC - 8oC
Instructions for Use and Handling
Shake well before use. Discard if vaccine cannot be re-suspended. Abhay - TOXTM
must not be diluted to administer.

Back
For The Use Of Registered Medical Practioner Or Hospital Or Laboratory Only
Abhay-DAGTM Vaccine
DIPHTHERIA AND TETANUS VACCINE (ADSORBED) I.P.
DESCRIPTION
Diphtheria and Tetanus Vaccine (Adsorbed) is a sterile, whitish turbid, uniform sus-
pension containing purified diphtheria and tetanus toxoids. The toxoids are adsorbed
on Aluminium phosphate and Thiomersal (0.01%) is used as preservative.
COMPOSITION
Each dose of 0.5ml contains
Active ingredients:
Diphtheria toxoid > 20 Lf to < 30Lf
Tetanus toxoid > 5Lf to < 25Lf
Other ingredients:
Adsorbed on Aluminium phosphate (AlPo4) >1.5mg
Thiomersal 0.01%
INDICATIONS AND USAGE
Abhay-DAGTM Vaccine is indicated for the primary immunization of infants, at or above
the age of two months, and of pre-school children against diphtheria and tetanus to
whom simultaneous immunization against Pertussis is not required.
Three intramuscular injections of 0.5ml at least four weeks apart followed by a fourth
dose provide primary immunization for children.
ADMINISTRATION
The vaccine vial should be shaken before use to homogenize the suspension. The
vaccine should be injected intramuscularly. Sterile needle and syringes only should
be used for each injection. The most preferred site of injection in infants and younger
children is the anterolateral aspects of the upper thigh and the deltold muscle in older
children.
PRECAUTIONS
For anaphylactic reactions, adrenaline (1:1000) may be used.
WARNINGS
Persons receiving immunosuppressive drugs may not develop an optimum immune
BACK
TO
PRODUCT
RANGE
response. Continuous booster doses of tetanus toxoid in the presence of excessive
serum levels of tetanus anti toxin is associated with increased incidents of reactions
and should be avoided.
SIDE EFFECTS
Erythema, tenderness and pain at the site of injection are common and may be
associated with occasionally mild to moderate systemic fever.
CONTRAINDICATIONS
Diphtheria and Tetanus vaccine (Adsorbed) should not be administered to
- Infants or children with high fever or acute illness.
- Older children (after seven years of age) or to adults.
- Child who suffered a severe reaction to the previous dose.
SPECIAL PRECAUTIONS FOR STORAGE
Abhay-DAGTM should be stored and transported between +2oC and +8oC.
IT MUST NOT BE FROZEN
Once opened, multi dose vials should be kept between +20C and +80 C. Multi dose
vials of Abhay-DAGTM from which one or more doses of vaccine have been removed
during an immunization session may be used in subsequent immunization sessions
upto a maximum 4 weeks, provided that all of the following conditions are met.
- The expiry date has not passed.
- The vaccine is stored under appropriate cold chain conditions.
- The vaccine vial septum has not been submerged in water.
- Aseptic technique has been used to withdraw all doses.
PRESENTATION
Abhay-DAGTM is supplied in:
- Multi dose rubber stoppered glass vials.
For The Use Of Registered Medical Practioner Or Hospital Or Laboratory Only
Abhay-TAGTM Vaccine
DIPHTHERIA, TETANUS AND PERTUSSIS VACCINE (ADSORBED) I.P.
DESCRIPTION
Diphtheria, Tetanus and Pertussis Vaccine (Adsorbed) is a sterile, whitish turbid, uni-
form suspension of diphtheria, tetanus toxoids and pertussis vaccine adsorbed on
Aluminium phosphate and Thiomersal (0.01%) is used as preservative.
COMPOSITION
Each dose of 0.5ml contains
Active ingredients:
Diphtheria toxoid > 20 Lf to <30Lf
Tetanus toxoid > 5Lf to < 25Lf
B. pertussis > 4 IU
Other ingredients:
Adsorbed on Aluminium phosphate (AIPo4) > 1.5mg
Thiomersal 0.01%
INDICATIONS AND USAGE
Abhay-TAGTM Vaccine is indicated for the primary immunization of infants, at or above
the age of 6 weeks and of children through six years of age against diphtheria, teta-
nus and whooping cough.
Three intramuscular injection of 0.5ml should be given on 3 separate occasions at 4
weeks interval provide primary immunization for children. The first dose should be
started as early as 6 weeks of age. Booster doses should be given 12 months after
the primary immunization and also between the ages of 4-6years.
ADMINISTRATION
The vaccine vial should be shaken before use to homogenize the suspension. The
vaccine should be injected intramuscularly. The anterolateral aspect of the upper
thigh is the preferred site of injection. A sterile needle and sterile syringe should be
used for each injection. It must not be injected into the skin as this may give rise to
local reaction.
PRECAUTIONS
For anaphylactic reactions, adrenaline (1:1000) may be used.
BACK
TO
PRODUCT
RANGE
WARNINGS
Abhay-TAGTM should be used only for infants and children from 6 weeks through 6
years of age. Persons receiving immunosuppressive drugs may not develop an
optimum immune response. Continuous booster doses of tetanus toxoid in the pres-
ence of excessive serum levels of tetanus antitoxin is associated with increased inci-
dents of reactions and should be avoided. Tetanus toxoid should be used for booster
doses if the hypersensitivity to the diphtheria component is suspected
SIDE EFFECTS
Mild local or systemic reactions are common. Some temporary swelling, tenderness
and erythema at the site of injection together with fever occur in a large proportion of
cases. Severe reactions of high fever, irritability, drowsiness, persistant or unusual
crying symptoms develop within 24 hours of administration occur frequently following
injections of this vaccine. Occasionally severe reactions of high fever, collapse and
screaming develop within 24 hours of administration. Febrile convulsions have been
reported at a rate of one per 12500 doses administered.
CONTRAINDICATIONS
Diphtheria, Tetanus and Pertussis vaccine (Adsorbed) should not be administered to
- Infants or children with high fever or acute illness.
- Presence of neurological disorder.
- Older children (after six years of age) or to adults.
- Child who suffered a severe reaction to the administration of this vaccine
earlier.(fever over 400C, convulsion, screaming episodes and collapse.)
SPECIAL PRECAUTIONS FOR STORAGE
Abhay-TAGTM should be stored and transported between +2oC and +8oC.
IT MUST NOT BE FROZEN
Once opened, multi dose vials should be kept between+2oC and +8oC. Multi dose
vials of Abhay-TAGTM from which one or more doses of vaccine have been removed
Continued
 BACK
TO
PRODUCT
RANGE

during an immunization session may be used in subsequent immunization session

upto a maximum 4 weeks, provided that all of the following conditions are met.
- The expiry date has not passed.
- The vaccine is stored under appropriate cold chain conditions.
- The vaccine vial septum has not been submerged in water.
- Aseptic technique has been used to withdraw all doses.

PRESENTATION
Abhay-TAGTM is supplied in:
- Single dose rubber stoppered glass vials.
- Multi dose rubber stoppered glass vials.

Back